Intrapersonal and Interpersonal Factors Predicting Distress and End-of-Life Planning among Individuals with Advanced Cancers by Panjwani, Aliza A
City University of New York (CUNY) 
CUNY Academic Works 
All Dissertations, Theses, and Capstone 
Projects Dissertations, Theses, and Capstone Projects 
9-2020 
Intrapersonal and Interpersonal Factors Predicting Distress and 
End-of-Life Planning among Individuals with Advanced Cancers 
Aliza A. Panjwani 
The Graduate Center, City University of New York 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/gc_etds/3942 
Discover additional works at: https://academicworks.cuny.edu 







INTRAPERSONAL AND INTERPERSONAL FACTORS PREDICTING DISTRESS AND 



















A dissertation submitted to the Graduate Faculty in Psychology in partial fulfillment of the 



























ALIZA A. PANJWANI 





Intrapersonal and Interpersonal Factors Predicting Distress and End-of-Life Planning among 
Individuals with Advanced Cancers 
by 
Aliza A. Panjwani, M.A 
 
This manuscript has been seen read and accepted for the Graduate Faculty in Psychology in 









Date Tracey A. Revenson 






Date Richard Bodner 



















Intrapersonal and Interpersonal Factors Predicting Distress and End-Of-Life Planning Among 
Individuals with Advanced Cancers 
by 
 
Aliza A. Panjwani  
 
 
Advisor: Tracey A. Revenson 
 
 
The social-cognitive processing model of adaption to cancer posits that both intrapersonal and 
interpersonal factors influence psychological adjustment (Lepore, 2001). In this dissertation, two 
intrapersonal factors, intolerance of uncertainty (IU) and experiential avoidance (EA), were 
examined in relation to emotional distress (psychological outcome) and advanced care planning 
(behavioral outcome) among patients living with advanced cancer. EA (efforts intended to avoid 
negative emotions, thoughts, images or memories) was hypothesized to mediate the relationship 
between IU (the ability to tolerate uncertainty or the unknown) and emotional distress. In line 
with the social-cognitive model, two interpersonal factors, social support from family and friends 
and patient trust in physician, were proposed to buffer the indirect influence of IU on distress 
through EA. IU and EA were hypothesized to interact to predict advanced care planning (ACP), 
such that those higher on IU and EA would engage in less ACP compared to those higher on IU 
but lower on EA. The sample included 108 adults with Stage III or IV cancer (53% female; Mage 
= 63 years). All constructs were measured by standardized self-report scales with acceptable to 
strong internal consistency reliability (i.e., Intolerance of Uncertainty Scale-Short Form; The 




Questionnaire; Trust in Physician Scale; Hospital Anxiety and Depression Scale; Advanced Care 
Planning Checklist). The PROCESS macro for SPSS was used to conduct mediation, 
moderation, and conditional process analyses. IU evidenced both direct and indirect relationships 
with anxiety and depressive symptoms. However, the indirect influence of IU through EA was 
not contingent on social support. Patient trust in physician did moderate the indirect relationship 
between IU and anxiety (but not depressive symptoms), albeit in an unanticipated direction. 
Specifically, the indirect relationship between IU and anxiety symptoms (through EA) was 
significant for those with moderate to high physician trust but not low trust. Moreover, 
moderation analyses showed that EA did not influence the positive direct association between IU 
and ACP. Post-hoc multiple regression analysis, including age, emotional distress, interpersonal 
factors (social support and trust in physician) and intrapersonal factors (IU and EA), 
demonstrated that only age and EA remained significant predictors of ACP. Accounting for other 
factors, older participants engaged in more ACP and those who were more experientially 
avoidant engaged in less ACP. Although this dissertation used a social-cognitive processing 
model in which intrapersonal and interpersonal factors interact to predict adjustment, the overall 
findings provide stronger support for the salience of intrapersonal factors in influencing 
emotional distress and ACP. IU and, in particular, EA are identified as targets for intervention 
aimed at helping individuals with advanced cancer manage the emotional impact of illness and 
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Chapter One: Introduction 
In 2017, approximately 1,690,000 individuals in the United States received a cancer 
diagnosis and over 600,000 were estimated to die from the illness (National Cancer Institute, 
2017). Consequently, an increasing number of people will be facing advanced cancer and the 
possibility of a nearing death. Usually classified as Stage III or IV, advanced cancer is defined as 
cancer that cannot be cured or controlled with treatment and/or has spread to other parts of the 
body (American Cancer Society, 2017). Although treatment may prolong life, the goal is often 
palliative, involving the management of illness-related symptoms and preservation of quality of 
life (World Health Organization, 2017). Individuals with advanced cancer are tasked with 
understanding complex medical and prognostic information (Chochinov et al., 2000) and making 
difficult treatment decisions (Parks & Winter, 2009), while managing the emotional impact of a 
life-limiting illness (Hwang, Chang, Fairclough, Cogswell & Kasimis, 2003). 
Mood disorders such as depression are among the most studied psychological outcomes 
in patients with cancer (Hotopf, Chidgey, Addington-Hall & Lan, 2002). Though studied less 
frequently, anxiety is also thought to be prevalent among this population (Roy-Byrne et al., 
2008). Estimates of anxiety and depression vary considerably across the cancer trajectory (e.g., 
at diagnosis, during treatment) and depend on the assessment tool, study settings, and sample 
selection and size (Burgess et al., 2005; van't Spijker et al., 1997). In a sample of over 10,000 
patients with a range of cancers, approximately 19.0% of patients reported clinical levels of 
anxiety and another 22.6% reported subclinical symptoms. Further, 12.9% of patients reported 
clinical symptoms of depression and an additional 16.5% described subclinical symptoms 
(Linden, Vodermaier, MacKenzie & Greig, 2012).  




found and reviews tend to be organized by cancer type (Caplette-Gingras & Josée Savard, 2008 
Watts, Prescott, Mason, McLeod & Lewith, 2015), making comparison across cancer sites 
difficult. One study found that the proportion of cancer patients in palliative care (59%) reporting 
general distress was more than double that of outpatients (24.5%) or general community samples 
(16.5%; Gao, Bennett, Stark, Murray & Higginson, 2010). Among 216 individuals with 
advanced cancer, 37% and 44% reported clinically significant depression and anxiety symptoms, 
respectively (Delgado-Guay, Parsons, Li, Palmer & Bruera, 2009). Overlooking or 
underestimating the psychological sequelae of advanced cancer can have significant 
consequences, such as worsening physical and health symptoms (Kershaw et al., 2015) and 
quality of life (Smith, Gomm & Dickens, 2003). When patients with chronic illness were 
compared to those with chronic illness and comorbid depression and anxiety, the latter group 
reported a higher number of medical symptoms, even after controlling for disease severity 
(Katon, Lin & Kroenke, 2007).  
The Social-Cognitive Processing Framework of Psychological Adjustment to Cancer  
As cancer is a potentially life-threatening disease, it has been conceptualized as a 
traumatic experience (Cordova et al., 2007), calling into question individuals’ beliefs about 
themselves, the world, and the future. Adjustment, a commonly used term in the study of chronic 
illnesses such as cancer, consists of psychological (Lazarus & Folkman, 1984) and social 
(Kornblith, 1998) processes through which individuals manage various illness events, stressors 
or demands (Hoyt & Stanton, 2019; Stanton, Revenson & Tennen, 2007).  Although it is well-
established that the experience of cancer can disrupt subjective well-being (Aziz, 2007), 




Raque-Bogdan, 2013; Stanton et al., 2015) and can inform targets for intervention (Brennan, 
2001; Stanton, Luecken, MacKinnon & Thompson, 2015).  
The experience of cancer can challenge the assumption that life is generally predictable 
and fair (Strada & Sourkes, 2010). Cognitive processing theories posit that adjustment involves 
processing and integrating trauma-related information into individuals’ existing mental models 
of themselves and the world (Horowitz, 1986). Although person-level factors such as cognitive 
filters and personality traits play significant roles, the contribution of individuals’ social 
environments to adjustment is not included in these theories (Lepore, 2001). According to the 
social-cognitive processing (SCP) model, a psychosocial framework for adaptation to cancer, 
both intrapersonal and interpersonal factors are important for adjustment (Lepore, 2001).  
Intrapersonal factors influence the schemas through which individuals with cancer view their 
world, but these factors may interact with individuals’ social context and environment (Mischel, 
1990). The current study examined both intrapersonal and interpersonal factors related to 
emotional distress among individuals living with advanced cancers. 
Intrapersonal Factors: Intolerance of Uncertainty and Experiential Avoidance  
Intolerance of uncertainty (IU) is a dispositional characteristic that results from “a set of 
negative beliefs about uncertainty and its implications and involves the tendency to react 
negatively on an emotional, cognitive, and behavioral level to uncertain situations and events” 
(Buhr & Dugas, 2009, p. 216). Previous research has found that IU is a transdiagnostic construct 
across a host of psychological conditions in both clinical (Gentes & Ruscio, 2011) and chronic 
illness populations (Panjwani et al., 2017). Consequently, IU is proposed as a person-level factor 
related to greater emotional distress, specifically anxiety and depression, among individuals with 




Worry (McEvoy & Mahoney, 2012) and rumination (Yook, Kim, Suh, & Lee, 2010) are  
commonly examined mediators of the relationship between IU and distress. However, a 
mechanism that has received far less attention and yet may underlie this relationship is 
experiential avoidance (EA). EA refers to attempts to avoid or escape unpleasant internal 
experiences such as thoughts, feelings, memories, images and sensations (Hayes, Wilson, 
Gifford, Follette & Strosahl, 1996). Although the purpose of these efforts may be to reduce 
distress, they paradoxically lead to greater symptomatology, such as increased depression and 
anxiety (Hayes, Strosahl & Wilson, 2011; Hayes et al., 1996). The research on EA has been 
largely conducted among college students, community-residing adults and individuals with 
psychiatric disorders (Gámez et al., 2014; Gámez, Chmielewski, Kotov, Ruggero & Watson, 
2011; Hayes, Pistorello, & Levin, 2012), and not medically-ill populations. EA is hypothesized 
to mediate the relationship between IU and emotional distress among individuals with advanced 
cancer.   
 Interpersonal Factors: Social Support and Trust in Physician 
In line with the broader social-cognitive processing model, the relationship between 
intrapersonal factors and adjustment may be influenced by the social context (Hoffman et al., 
2013; Lepore, 2001; Roberts, Lepore & Helgeson, 2006). Two such factors are perceived social 
support and patient trust in medical providers. Social support is often studied in chronic illness 
populations with reference to family and friends, also referred to as informal social networks 
(Uchino, 2006; Wills & Ainette, 2012). Research on individuals with cancer has demonstrated 
that perceived support from close others is associated with lower distress (Mehnert, Lehmann, 
Graefen, Huland & Koch, 2010) and better quality of life (Trevino, Fasciano, Block & Prigerson, 




social support buffers the impact of stressful life events on psychological adjustment (Cohen, 
Gottlieb, & Underwood, 2000; Wills & Ainette, 2012). Few studies have examined whether the 
stress buffering effects of social support remain in the context of advanced cancer, where 
patients often experience significant psychological and physical symptom burden (Laird et al., 
2011). 
 In addition to patients’ relationships with family or friends, the relationship between 
patients and physicians also deserves consideration. Trust in physician refers to patients’ 
attitudes or beliefs that the physician will act in the patients’ best interest even when patients are 
highly vulnerable (Anderson & Dendrick, 1990; Thom, Hall & Pawlson, 2004). Studies have 
found that greater trust in physician is correlated with better adherence to medical 
recommendations, fewer conflicts with the medical team, and greater satisfaction with care (Hall, 
Dugan, Zheng, & Mishra, 2001; Hamano et al., 2017). A recent study of patients with advanced 
cancer showed a significant relationship between trust in physician and better quality of death 
(Hamano et al., 2017); however, this construct is understudied in relation to the patients’ 
emotional well-being.  
Drawing on the social-cognitive framework and the stress-buffering hypothesis, this 
study examines a proposed theoretical model, depicted in Figure 1. In this model, the mediating 
influence of EA underlying the relationship between IU and distress—an intrapersonal process—
is moderated by interpersonal factors, namely, social support and trust in physician.  
Advanced Care Planning 
Living with advanced cancer involves considerable uncertainty around illness 
progression and prognosis (Benzein, Norberg, & Saveman, 2001). Patients often report a limited 




management (Wong et al., 2002). Symptoms can worsen and health can deteriorate 
unexpectedly. Advanced care planning is a process of reflection and communication with 
medical providers and family members, in which individuals make decisions regarding their 
future health and medical care in case they become incapable of providing informed consent at a 
later stage. Discussions can involve decisions around life-prolonging treatment preferences and 
care at end-of-life, such as establishment of do-not-resuscitate or other advanced care directives 
(Lovell & Yates, 2014; Singer et al., 1998). Although some patients accept the possibility of 
death (Higginson & Constantini, 2008), others experience uncertainty around dying and avoid 
thinking about the future or engage in suppression of distressing thoughts (Devik et al., 2013). 
Although advanced care planning is related to lower distress and a more dignified death 
(Detering, Hancock, Reade, & Silvester, 2010), the rate of advanced care planning in the United 
States is as low as 5 to 15% (Jones, Moss, & Harris-Kojetin, 2011).  
According to the contexts of death awareness theory (Timmermans, 1994), patients with 
a terminal illness progress through stages of awareness. In the uncertain open awareness stage, 
patients may selectively hold onto prognostic information, disregarding some of the negative 
information provided by the medical team. In this sense, “life is lived in a state of limbo” 
(Borneman, Irish, Sidhu, Koczywas, & Cristea, 2014, pp. 272). When in the active open 
awareness stage, patients are thought to have accepted that the illness is incurable and 
confronted emotions like despair and hopelessness. As such, patients have a higher likelihood of 
engaging in discussions about the process of dying and related matters in this stage 
(Timmermans, 1994).  
Confronting fears about mortality as well as uncertainty about the future (Zimmermann, 




that patients unequivocally accept their death (such as in active open awareness); rather, 
acceptance is determined by how they respond internally to this [uncertain] information 
(Timmermans, 1994). Given that adjustment is also evidenced by behavioral indices (de Moor et 
al., 2002) and so little is known about how patients make end-of-life decisions, intrapersonal 
processes such as IU and EA were also explored in the context of advanced care planning. As 









Chapter Two: Literature Review  
The literature review of this dissertation is divided in two parts. First, the research on the 
relationships between intolerance of uncertainty (IU), experiential avoidance (EA), and 
emotional distress is reviewed. The potential moderating roles of social support and trust in 
physician are also explored. The second part of the review is centered on the potential roles of IU 
and EA in the process of advanced care planning. As no studies have examined these factors 
together in a sample of patients with advanced cancer, the review will present models and 
evidence from the fields of clinical psychology, health psychology, and medicine.  
Intolerance of Uncertainty and Emotional Distress 
Those who are more intolerant of uncertainty find the “unknown” threatening and the 
possibility of a negative event occurring unacceptable, upsetting and unfair (Carleton et al., 
2012). When faced with ambiguous stimuli, individuals high on IU make more threatening 
interpretations compared to those who are low on IU (Dugas et al., 2005). In addition to negative 
reactions towards possible future threat, IU also refers to beliefs regarding the inability to 
manage ambiguity or unpredictability, which only worsens perceptions of threat (Holaway, 
Heimburg & Coles, 2006).  
The significance of IU as a transdiagnostic factor across various psychiatric disorders has 
been well-established in the clinical science literature (see Gentes & Ruscio, 2011 for a meta-
analysis; Carleton, 2012). IU has been studied as an antecedent to generalized anxiety disorder 
(Dugas et al., 2007), social anxiety disorder (Boelen & Reijntjes, 2009), obsessive-compulsive 
disorders (Holaway et al., 2006) and panic (Buhr & Dugas, 2009). Some experimental work has 




Dugas, 2000), a vulnerability factor for various anxiety disorders, even after accounting for self-
control and perfectionism (Laugesen, Dugas & Bukowski, 2003).   
Several studies have also documented the role of IU in depression (Liao & Wei, 2011; 
McEvoy & Mahoney, 2012). IU predicts the tendency to ruminate (Yook, Kim, Suh & Lee, 
2010), a precipitating factor for depression and negative affect (Michl, McLaughlin, Shepherd & 
Nolen-Hoeksema, 2013; Nolen-Hoeksema & Morrow, 1991). IU is also related to hopelessness 
(Miranda, Fontes & Marroquín, 2008), another defining feature of depression (Beck, Riskind, 
Brown & Steer, 1988). Meta-analytic findings demonstrate robust associations between IU and 
anxiety as well as IU and depressive disorders (Gentes & Ruscio, 2011).  
IU has been investigated in non-clinical populations, such as college (Berenbaum, 
Bredemeier & Thompson, 2008) and community samples (Sexton & Dugas, 2009). In these 
populations, IU demonstrates a generally normal distribution and range of scores. As such, IU’s 
relevance is not restricted to individuals who have psychiatric disorders but is also applicable to 
those who are healthy or with medical conditions (Alschuler & Beier, 2015). In the past decade, 
researchers have studied the link between IU and distress among patients with a number of 
disease conditions, such as diabetes (Rasmussen et al., 2013), inflammatory bowel disease 
(Keefer et al., 2005), Meniere’s disease (Kirby & Yardley, 2009), Parkinson’s disease (Brown & 
Fernie, 2015) and cancer (Tan et al., 2016). 
The relationship between IU and emotional well-being has been examined at different 
points during the illness trajectory with cancer patients and survivors. Among 119 men with 
prostate cancer being treated with active surveillance, IU was related to both general and cancer-
specific anxiety in the year following diagnosis (Tan et al., 2016). In another study of 70 prostate 




even after controlling for physical symptoms (Eisenberg et al., 2015). Among a small sample of 
lung cancer patients approaching the end of initial treatment, IU was associated with worry and 
depressive symptoms (Kurita, Garon, Stanton & Meyerowitz, 2013). 
Despite evidence for the positive association between IU and distress among individuals 
with chronic illness, including cancer (Kurita et al., 2013; Tan et al., 2016), the relationship 
remains unexamined in individuals with advanced cancer. Taken together with the studies of 
patients in the active treatment and survivorship phases of the cancer trajectory, the broader 
clinical literature on IU and psychological disorders suggests that the association between IU and 
distress will remain significant in advanced stages of cancer. What is less clear, however, is what 
mechanisms underlie the relationship between IU and distress in chronic illnesses (Panjwani et 
al., 2017).   
Experiential Avoidance and Distress 
Distressing thoughts and avoidance. “No matter what you do, don’t think of the white 
polar bear.”  To deliberately avoid a distressing thought or idea, humans—being a verbal 
species—form a verbal rule, which involves the very thought they are trying to escape. 
Therefore, self-regulatory efforts to not think particular thoughts generate those same thoughts; 
in effect, the thought ‘rebounds’ (Wegner, Schneider, Knutson & McMahon, 1991). The 
suppression of unwanted thoughts is associated with more intrusive thoughts (Najmi & Wegner, 
2008), negative affect (Cheavens & Heiy, 2011), general stress (Erskine, Georgiou, & 
Kvavilashvili, 2010), post-traumatic stress (Beck, Gudmundsdottir, Palyo, Miller & Grant, 
2006), anxiety (Hooper, Davies, Davies & McHugh, 2011), depression (Szasz, 2009), and 




analysis on the effects of thought suppression supports the existence of this rebound effect 
(Abramowitz, Tolin & Street, 2001) in both clinical and non-clinical samples. 
Although the literature on thought suppression and ensuing emotional distress cited 
above comes from the clinical literature, a parallel body of research can be found in health 
psychology and psycho-oncology, focusing on the concept of intrusive thoughts. Intrusive 
thoughts are defined as recurrent, unwanted thoughts or images about a specific stressor that 
serve as stimuli for cognitive avoidance or indicate unsuccessful avoidance efforts (Lepore & 
Helgeson, 1998; Zilberg, Weiss & Horowitz, 1982). In cross-sectional studies of individuals with 
cancer, intrusive thoughts have been associated with indicators of adjustment, such as depressive 
symptoms (Anagnostopoulos, Slater & Fitzsimmons, 2010), anxiety (Whitaker, Watson & 
Brewin, 2009), fear of cancer progression (Mehnert, Berg, Henrich & Herschbag, 2009), lower 
quality of life (Lewis et al., 2001) and worse physical functioning (Kaasa et al., 1993).  
Prospective research has shown that intrusive thoughts contribute to psychological 
distress. The prevalence of intrusive thoughts at time of surgery predicted depressive symptoms, 
anxiety, and lower quality of life three months later in men with prostate cancer (Thorsteinsdottir 
et al., 2013). Among women with breast cancer, intrusive thoughts post-operation predicted 
distress two years past the initial diagnosis (Bleiker, Pouwer, van der Ploeg, Leer & Ader, 2000). 
In a longitudinal study of women with ovarian cancer, increases in intrusive thoughts were 
related to increases in anxiety and depression three months after the completion of 
chemotherapy. Similar effects of other disease parameters (e.g., illness severity) on 
psychological adjustment were not found (Hipkins, Whitworth, Tarrier & Jayson 2004). 
Distressing emotions and avoidance. In addition to evoking distressing thoughts, living 




can be difficult to regulate (Anderson et al., 2008). Avoidance or suppression of these emotions 
has been associated with poorer adjustment to the illness (Cordova et al., 2003; Panagopoulou, 
Kersbergen & Maes, 2002). Emotion suppression is also related to lower physiological and 
immune functioning (Penedo et al., 2006). In studies of non-advanced cancer patients,  
avoidance or denial of emotions has been related to greater distress (Classen, Koopman, Angell, 
& Spiegel, 1996; Cohen, 2013), whereas emotional expression has been related to lower distress 
(Iwamitsu et al., 2005; Stanton et al., 2000). Although most of this research has been conducted 
with patients in earlier stages of disease (e.g., Iwamitsu et al., 2005; Roesch et al., 2005), the 
mechanisms likely operate similarly in the context of advanced cancer, given that it can evoke 
powerful distressing emotions such as anger, grief, and sadness (Anderson et al., 2007; Jacobsen, 
Zhang, Block, Maciejewski & Prigerson, 2010; Viney et al., 1994).  
Experiential avoidance. Avoidance of internal events is often operationalized as either 
thought suppression (Magee, Hartman & Teachman, 2012) or emotion suppression (Cisler, 
Bunmi, Olatunji, Feldner & Forsyth, 2010), although these processes likely co-occur (Hayes et 
al., 2012). According to the acceptance and commitment therapy (ACT) framework, EA is a 
construct denoting an unwillingness to stay in contact with a range of distressing private events, 
including thoughts, emotions, images, memories or sensations, even when doing so is unhelpful 
in the long-term (Hayes et al., 2011). Individuals high on EA exert concerted efforts to control or 
change how often and how long they experience both these internal events and the situations that 
evoke them (Hayes et al., 2012). With regard to advanced cancer, EA may manifest as avoiding 
thoughts about prognosis, disengaging from situations that serve as reminders of the possibility 




strategy like thought or emotion suppression alone but rather serves an overall regulatory 
purpose that is highly relevant in the context of advanced cancer.  
EA has been examined by clinical researchers primarily in relation to psychopathology 
(Chawla & Ostafin, 2007) and behavioral disorders (Shorey et al., 2017). There is considerable 
support for the role of EA in predicting depression, generalized anxiety disorder, and panic 
disorder (Spinhoven, Drost, de Rooij, van Hemert & Penninx, 2014). However, longitudinal 
research on EA in psycho-oncology is relatively sparse, with some exceptions. In an intervention 
based on psychoeducation and cognitive behavioral therapy (CBT) with 54 breast cancer patients 
(94% within one year from diagnosis), reductions in EA predicted small decreases in anxiety and 
depression (Aguirre-Camacho et al., 2017). Although the intervention was not designed to 
explicitly address EA, the authors speculated that if EA had been included as a specific target, 
greater improvements in distress outcomes may have been possible.  
This suggestion is supported by findings from a study comparing ACT to a treatment-as-
usual condition among women with advanced ovarian cancer (Stage III and IV). The latter 
condition included commonly used CBT components, such as cognitive restructuring. Patients 
who were assigned to the ACT arm evidenced greater declines in distress and improvements in 
quality of life compared to those assigned to the CBT arm. Moreover, the gains in the ACT 
group were mediated by decreases in EA (Rost, Wilson, Buchanan & Mutch, 2012). The authors 
did not use a single measure of EA; instead, they utilized a number of different assessment tools 
to assess its components and examined changes in these components separately.  
Although EA can be conceptualized as self-regulatory and protective (Hayes, Jacobson, 
Follette & Dougher, 1994), the literature described above demonstrates that efforts to inhibit or 




distress they can cause (Cioffi & Holloway, 1993; Gross, 2002; Hayes et al., 1996). In humans, 
intentional avoidance usually consists of forming and adhering to a verbal plan. For example, if a 
patient with advanced cancer desired to eliminate an intrusive thought (e.g., “am I going to 
die?”), he or she would form a verbal rule that would contain the intrusive thought in question 
(e.g., “I can’t think about dying”). Furthermore, there is a sizable body of evidence suggesting 
that decreases in EA are associated with improvements in distress and quality of life outcomes 
(Aguirre-Camacho et al., 2017; Hayes et al., 2012; Rost et al., 2012,).  
The Relationship between Intolerance of Uncertainty and Experiential Avoidance 
Individuals who are more intolerant of uncertainty may be motivated to regulate their 
internal experience in maladaptive ways, such as through EA. Although EA is a broader 
construct than cognitive avoidance (Karekla & Panayiotou, 2011), both theory and research on 
cognitive avoidance inform the hypothesized relationships between IU and EA. According to the 
cognitive avoidance theory, individuals may avoid invoking threatening thoughts and mental 
images to prevent more pronounced feelings of distress (Borkovec, Alcaine & Behar, 2004). 
Evidence suggests that individuals high on IU who find the possibility of a future threat 
unacceptable may regulate emotions through the use of cognitive avoidance strategies (Dugas, 
Marchand, & Ladoucer, 2005), such as thought suppression (Borkovec, Ray & Stöber, 1998; 
Laugesen et al., 2003).  
A few clinical studies have examined the relationship between IU and EA to each other 
and to distress. In a treatment study comparing 50 individuals who met criteria for generalized 
anxiety disorder to 41 demographically-matched controls, higher IU was related to greater EA. 
The anxious group reported the greatest EA and distress about emotions (Lee, Orsillo, Roemer & 




between fear of uncertainty (a construct related to IU) and psychological distress (Berrocal, 
Pennato & Bernini, 2009).  
The supposition that EA mediates the relationship between IU and distress is consistent 
with the limited literature on IU and avoidant coping among studies of individuals with cancer. 
For example, Taha, Matheson and Anisman (2012) found that IU was associated with both 
depressive symptoms and avoidant coping among women who completed treatment for breast 
cancer. Similarly, in a study of lung cancer patients, Kurita et al. (2013) found that the significant 
positive association between IU and depressive symptoms was fully mediated by avoidant post-
traumatic stress symptoms. Taken together, both theory and empirical evidence described above 
suggest that EA is a viable mechanism underlying the association between IU and distress even 
though there is currently limited research examining these two constructs together.   
The Influence of Social Support from Loved Ones and Patient Trust in Physician  
Most of the research on IU and distress has focused on intrapersonal processes, not 
interpersonal ones. Adaptation to chronic illness does not occur in a social vacuum (Revenson & 
Lepore, 2012) and research has shown that friends and family are critical in coping with chronic 
illness (Reblin & Uchino, 2008; Uchino, 2006; Wills & Ainette, 2012). Similarly, patients’ 
relationship with their physician, particularly in the context of cancer, may be critical for 
adaptation. One aspect of this relationship that has received considerable attention is the patient’s 
trust in physician (Calnan & Rowe, 2006). In subsequent sections, the roles of support from 
family and friends as well as patient trust in the physician are examined as potential moderators 
of the intrapersonal processes involved in psychological adjustment.  
Social support. Social support refers to both the tangible and intangible assistance a 




2012). Social support in and of itself is a complex interpersonal process and has been assessed in 
myriad ways. Even among populations with cancer, the literature on social support is vast and 
cannot be reviewed in its entirety here (Luszczynska, Pawlowska, Cieslak, Knoll & Scholz, 
2013; Nausheen, Gidron, Peveler & Moss-Morris, 2009). Instead, the section below centers on 
literature suggesting that social support may moderate the complex relationships among IU, EA, 
and emotional distress.  
According to the stress-buffering hypothesis, even the perception of the availability of 
support (versus its receipt) in one’s social environment can mitigate the deleterious effects of 
stress on adaptation to chronic illness such as cancer (Cohen & Wills, 1985; Wills & Ainette, 
2012). For example, in a study of women with head and neck cancer, social support buffered the 
impact of physical disfigurement on depression (Katz et al., 2003). Similarly, in a cross-sectional 
study of 80 prostate cancer patients, low social support moderated the effect of high stress on 
positive mood (Benedict et al., 2015). Social support also moderated the effects of cancer-related 
intrusive thoughts on quality of life among breast cancer survivors; among those who had high 
perceived support, the relationship between intrusive thoughts and quality of life was non-
significant (Lewis et al., 2001).  
Most studies on the stress-buffering effects of social support in cancer have involved 
patients with earlier stages of cancer, with a small subset examining social support as a stress 
buffer among patients with advanced cancer. In a prospective study of 53 patients with 
metastatic melanoma and renal cell cancer, individuals with low levels of support and high levels 
of intrusive thoughts and avoidance reported greater distress and poorer quality of life one month 
after treatment (Devine, Parker, Fouladi & Cohen, 2003). In a cross-sectional study of women 




previous life stress on mood disturbances (Koopman, Hermanson, Diamond, Angell & Spiegel, 
1998). Similarly, among 77 women with non-metastatic breast cancer who were within 10 
months of cancer treatment, social support moderated the effect of an intrapersonal dispositional 
factor, optimism, on adjustment. Specifically, social support buffered against the negative impact 
of low optimism on distress and psychosocial functioning (Shelby et al., 2013).  
Although there is large body of literature on social support as a stress buffer between 
negative life events and adjustment, there is a paucity of research examining how social support 
interacts with intrapersonal factors to influence emotional distress among patients with advanced 
cancer. Accordingly, as depicted in Figure 1, the negative mediating influence of EA on the 
relationship between IU and emotional distress is hypothesized to be weaker for individuals with 
higher social support compared to those with lower social support.  
Trust in physician. Patients’ trust in their physician is considered a significant element 
of an effectual patient-physician relationship (Becker & Roblin, 2008). It involves the belief that 
the physician is forthcoming and capable, acts in the patient’s interest, and maintains 
confidentiality (Hall et al., 2001). Trust has been associated with adherence to medical 
recommendations, satisfaction with care, and improved health (Mostashari et al., 1998; Safran et 
al., 1998). When patients undergoing surgery to remove a brain tumor trusted the physicians 
responsible for their care, feelings of anxiety, concern and fear decreased (Bernstein, Potvin, & 
Martin, 2004). Patient-centered care is associated with a host of positive outcomes, such as lower 
anxiety and depression, and greater quality of life (Aarts et al., 2012; Roberts, Cox, Reintgen, 
Baile & Gibertini, 1994). For example, in a cross-sectional study of over 400 breast cancer 
survivors (Waters, Arora, Klein & Han, 2010), high perceived risk of cancer recurrence was 




this relationship. Potentially, patients with high perceived risk and lack of trust (as compared to 
those with both high perceived risk and trust) may have been unsure as to whether the physician 
could competently diagnose and treat a recurrence, which in turn was related to greater distress. 
Trust in physician, therefore, may buffer against the influence of intrapersonal factors (such as 
IU and EA) on distress. With the exception of the Waters et al. (2010) study, no quantitative 
study of cancer patients has examined these factors together. As shown in Figure 1 and similar to 
the stress-buffering hypothesis for social support, among individuals with higher levels of trust in 
their physician, the indirect relationship between IU and emotional distress through EA was 
hypothesized to be weaker as compared to those with lower trust in their physician.   
Although more research on IU as an antecedent to EA is needed, theoretical and 
empirical work suggests that a positive association does exist (Borkovec et al., 2004; Dugas et 
al., 2005). EA can be conceptualized as a self-defense strategy in response to feeling distressed 
about a negative event occurring in the future (Hayes et al., 1996) and, as such, a partially 
automatic response. Therefore, the buffering effects of social support and trust in physician were 
hypothesized to act on the relationship between EA and distress rather than IU and EA. Figure 1 
depicts moderation of the indirect effect at this second stage of the adjustment process.  
Engaging in Advanced Care Planning: Potential Roles of IU and EA 
 Given that cancer remains the second leading cause of mortality in the United States 
(Heron & Anderson, 2016), advanced care planning is critical to examine among patients with 
advanced cancer (Institute of Medicine [IOM], 2015). Failing to engage in advanced care 
planning is related to greater distress for patients at end-of-life (Detering et al., 2010), a 
problematic bereavement process for the family (Wright et al., 2008), provision of medical 




that provide little therapeutic benefit to patient (Wright et al., 2008). Conversely, engaging in 
advanced care planning promotes receipt of quality care in line with patient preferences (Mack, 
Weeks, Wright, Block & Prigerson. 2008), participation in valued activities and completion of 
“unfinished business” (Kasl-Godley & Christie, 2014), and dying with dignity (Sizoo et al., 
2013). Once patients overcome their reluctance to take part in end-of-life discussions, they 
appreciate opportunities to share concerns and fears, learn more about their options, document 
advanced care planning preferences, and confront silence around the topic of dying (Simpson, 
2012). 
Engaging in discussions about end-of-life can be emotionally and cognitively taxing for 
individuals with advanced cancer and their loved ones. There is often a large degree of 
uncertainty around prognosis and population-based estimates of “time-left” (IOM, 2015). The 
process of advanced care planning may involve vacillating between feeling hope and fear as well 
as thinking about living and dying. The balance may be challenging to strike (de Boer, Dröes, 
Jonker, Eefsting & Hertogh, 2012) and the uncertainty difficult to tolerate. Though acceptance or 
“peaceful” awareness of terminal status (Ray et al., 2006) and readiness to engage (Fried et al., 
2011) may predict advanced care planning, more research examining individual differences is 
needed.  
Unlike the relationship between IU and distress, there is limited literature examining the 
association between IU and behavior, and no research on link between IU and advanced care 
planning. Fear of the unknown is at the core of IU, as the possibility of a negative event 
occurring in the future is threatening despite the probability and timing of its occurrence 
(Carleton, 2012; Carleton, Norton & Asmundson, 2007). Though neurocognitive evidence 




research suggests two possible pathways: Some individuals high on IU may act swiftly to reduce 
uncertainty despite potential consequences, whereas others may perseverate and not act 
(Luhmann, Chun, Yi, Lee & Wang, 2008). The relationship between IU and intention-to-act 
versus actual execution of behaviors may also be complex. In one experimental study where 
participants watched upsetting film clips shown to evoke sadness and fear, although individuals 
high in prospective IU believed that seeking information held some utility for easing their 
distress, they did not necessarily behaviorally seek that information (Ranney, Behar,  & 
Bartoszek, 2019).  
Prospect theory (Tversky & Kahneman, 1992) has been applied to issues of prevention 
(e.g., screening) and adherence and may be relevant for individuals with advanced cancers who 
need to engage in advanced care planning. Individuals may be deterred from engaging in actions, 
such as preventive cancer screening, if there is a risk of a negative outcome—that is, a positive 
result for disease—as a result of engaging in the behavior. Women who are told that 
mammography can detect breast cancer and early treatment increases positive health outcomes 
have to still face the possible costs of having breast cancer, which may motivate them to avoid 
the mammogram altogether (Rothman & Salovey, 1997). Although prospect theory has been 
primarily used to frame health messages for screening and illness detection, this same process 
may be triggered in advanced care planning, which is meant to be executed in advance so as to 
prevent negative outcomes for patients and their family (Simpson, 2012). However, discussions 
regarding end-of-life care with family members and the medical team, or executing an advanced 
directive itself, involves tolerating uncertainty and discomfort related to confronting the 
possibility of dying.  




(Carleton et al., 2016). For example, in an experimental study of IU and behavioral tasks, 
undergraduate students high on IU preferred smaller, immediately available rewards that were 
less valuable rather than larger, more valuable rewards that were temporally distal (Luhmann, 
Ishida & Hajcak, 2011). But what is risk-averse behavior in the context of advanced cancer? 
Confronting and accepting the possibility of dying in its totality is distressing and can weigh 
heavily on an individual. As such, a risk-averse behavioral outcome in this regard may be lack of 
action around end-of-life directives.  
Keeping in mind the prospect theory framework and mixed findings on IU and behavior, 
it is possible that for patients who are high on EA as well as IU, tolerating the possibility of 
dying may feel too “risky” and difficult to experience emotionally; these patients may be less 
likely to engage in behaviors such as advanced care planning. Although tolerating the possibility 
of dying may feel difficult for patients high on IU and low on EA, they may be motivated to 
reduce feelings of uncertainty by making preparations for end-of-life care. In other words, if 
patients are not avoiding thoughts, feelings, and behaviors related to end-of-life but rather 
accepting them, they may be more willing to engage in advanced care planning. Therefore, an 
exploratory aim of the study is to examine whether there is a relationship between IU and 
advanced care planning and whether it is moderated by EA.  
Conceptual Model and Hypotheses 
Distress as Psychological Outcome  
Drawing together the literature reviewed above, Figure 1 presents the conceptual model 
of the dissertation hypotheses involving intrapersonal and interpersonal factors in potentially 
explaining emotional distress among patients with advanced cancer.  




anxiety symptoms (Hypothesis 1a) and IU and depressive symptoms (Hypothesis 1b); these 
hypotheses were tested with simple mediation analyses. The mediating role of EA in the 
expected positive association between IU and anxiety symptoms was hypothesized to be weaker 
for patients with higher social support (Hypothesis 2a) and greater trust in physician (Hypothesis 
2b) as compared to lower social support and trust in physician. These hypotheses were tested 
with two second-stage moderated mediation models, respectively. Similarly, two second-stage 
moderated mediation models were also computed with depressive symptoms as the outcome: 
The mediating role of EA in the expected positive association between IU and depressive 
symptoms was hypothesized to be weaker for patients with greater social support (Hypothesis 
3a) and trust in physician (Hypothesis 3b) compared to those with lower social support and trust 
in physician, respectively.   
Advanced Care Planning as Behavioral Outcome  
 Given that there is little literature on the roles of IU and EA on behavioral adjustment, 
Figure 2 presents an exploratory conceptual model of intrapersonal factors and advanced care 
planning.  
Hypothesis. IU and EA will interact to predict advanced care planning such that those 
higher on IU and EA are expected to engage in less advanced care planning compared to those 





Chapter Three: Methods 
The dissertation was a secondary analysis of data collected as part of a cross-sectional 
study on prognostic awareness among individuals with advanced cancer (PI: Rosenfeld, NIH 
R21 186932).  
Sample and Recruitment 
 Sample. The eligibility criteria for the parent study on prognostic awareness described 
below also apply to this dissertation. Eligible participants over the age of 18 with advanced 
cancer (stage III or IV), receiving care as outpatients at Memorial Sloan Kettering (MSK), were 
recruited. Per electronic medical records, all approached individuals in the study had advanced 
cancer. Eligible participants were required to complete study survey instruments in English. 
Trained study staff members excluded individuals who were unable to speak English or provide 
meaningful informed consent. Potential participants were identified through weekly review of 
current MSK outpatient clinic lists.  
Sample size calculation. Sample size was calculated using the application MedPower 
(Kenny, 2017; https://davidakenny.shinyapps.io/MedPower/), a tool that estimates sample size 
for mediation analyses given a desired level for power and estimates of the size of paths a and b 
in the mediational model. This tool is designed to approximate bootstrap estimates of power. A 
Type I error rate of .05 and desired statistical power at .80 (i.e., Type II error rate of .20) was 
assumed. Effect sizes from literature on the mediational analyses of fear of uncertainty and 
experiential avoidance (EA) in clinical samples were used to approximate the size of paths α 
(.34) and β (.44) (Berrocal et al., 2009), as studies of cancer patients with these constructs do not 
exist. According to Cohen’s (1988) effect sizes for regression coefficients, .14, .39, and .59 




β = .44 is between a medium and large-sized effect (Cohen, 1988). With these parameter 
estimates, MedPower estimated the required sample size to be 77.   
Fritz and McKinnon (2007) empirically estimated the sample size required for mediation 
analyses given Type I and Type II error as well as the size of α and b paths in the mediation 
model. For medium effect sizes for both paths α and b in bootstrapped mediation analyses, Fritz 
and McKinnon recommend a sample size of 78. Although the study was powered to test the 
primary mediation hypotheses with 78 participants, this sample size is not enough to test 
moderated mediation. Because no pilot data were available for those analyses, a small to medium 
effect size (ƒ = .11) was assumed (a conservative estimate). With Type I error of .05 and desired 
power of .80, a sample size of 114 was sufficient to address the moderated-mediation hypotheses 
in the study (GPower, version 3.1; Faul, Erdfelder, Buchner & Lang, 2009). Because the study is 
cross-sectional, attrition was not a concern. 
Recruitment. Recruitment began in April 2018 and is ongoing.  For the secondary 
analysis presented here, recruitment of the sample spanned the course of ten months from April 
2018 to February 2019. Based on eligibility criteria, 625 patients had been approached for 
participation in the study, of whom 369 (59%) met eligibility criteria, by the end of February. Of 
those who were eligible,199 (54%) patients refused participation and 169 (46%) consented to 
participate. Of those who consented (n = 169), 7 (4%) patients withdrew from the study before 
data collection began and 43 (25%) were unreachable and did not complete the study. Because 
they were unreachable, it was not possible to ascertain why these 43 individuals did not 
participate. Overall, 117 patients (69% of those consented) completed the study between April 




removed during the initial phases of data analysis, leaving a sample of 108 individuals for 
analyses testing the hypotheses. 
Procedures 
Trained MSK clinical research coordinators approached patients waiting for routine clinic 
appointments to offer more information about the study. Potential participants were provided a 
summary outlining study procedures, and risks and benefits of participation. Using the language 
from a verbal consent script (Appendix A), the research assistant informed the patient about the 
study, evaluated the patient’s comprehension of information, and provided answers to any 
questions the patient had.  
Once the patient provided verbal consent, the study assistants documented it for proof-of-
confirmation that informed consent was obtained. Participants were given a copy of the written 
study summary and informed consent for their records. After obtaining informed consent, the 
research coordinator either gave the patient a paper copy of packet of questionnaires including 
the study instruments as well as sociodemographic and medical history measures or sent an 
online link to the full survey packet through REDCap. REDCap is a secure web application for 
building and managing online surveys and databases. Utilizing REDCap allowed participants to 
complete the survey outside of MSK. Each participant was assigned a unique study identification 
number. No identifying or HIPPA-protected information was collected in the questionnaires. 
Data were provided for this dissertation in the form of a de-identified data file. 
Institutional Review Board (IRB) approval was obtained for this study from MSK (see Appendix 
B). The project was considered exempt by the Hunter College Human Research Protection 






Intolerance of uncertainty. The Intolerance of Uncertainty Scale-Short Form (IUS-12) 
is a 12-item scale that assesses an individual’s dispositional (in)ability to endure the negative 
response that is activated by the perceived absence of information and sustained by the 
perception of uncertainty (Carleton, 2016; Carleton et al., 2007). The IUS-12 is a shortened 
version of the original 27-item Intolerance of Uncertainty Scale (Carleton et al., 2007; Freeston, 
Rhéaume, Letarte, Dugas & Ladouceur, 1994). Items are rated on a Likert scale ranging from 
one (not at all characteristic of me) to five (entirely characteristic of me) and summed to provide 
a total score, with higher scores indicating greater intolerance of uncertainty (IU; Cronbach’s 
alpha = .80). In a psychometric paper, the IUS-12 was correlated highly with the 27-item scale in 
two undergraduate samples (Carleton et al. 2007). IU has predicted anxiety (Carleton, Collimore 
& Asmundson, 2010), worry (Fergus & Wu, 2010), and depression (McEvoy & Mahoney, 2011) 
among both clinical (Gentes & Ruscio, 2011; Carleton et al., 2012) and non-clinical samples 
(Carleton et al., 2007). The measure has strong internal consistency reliability, with alpha 
coefficients range from .87 to .96 (Carleton et al., 2007; Hale et al., 2016) as well as good test-
retest reliability (~r = .77; Khawaja & Yu, 2010). IU has established convergent validity, 
demonstrating associations in the expected directions with measures of worry, fear of negative 
evaluation and anxiety (Hale et al., 2016; Khawaja & Yu, 2010). Divergent validity has also 
been shown, with IU correlating weakly and negatively with measures of extraversion (McEvoy 
& Mahoney, 2011).  
The IUS-12 provides a total score and two subscale scores (prospective IU and inhibitory 
IU). The inhibitory subscale is thought to measure uncertainty paralysis and the prospective 




score is used in the current study, as it accounts for significantly more common variance on 
adjustment outcomes than either subscale alone (Hale et al., 2016; Khawaja & Yu, 2010). 
Moreover, in confirmatory factor analyses conducted with samples of undergraduate men and 
women, all items had high loadings on the general IU factor (loadings ranged from .68 - .80) 
than either subscale factor (loadings ranged from .17 - .56 for inhibitory IU and .17 - .66 for 
prospective IU). In fact, only one or two items loaded higher than .50 on either subscale factor 
(Hale et al., 2016). This finding is consistent with the theoretical (and empirical) understanding 
of IU as a unifying, transdiagnostic factor in explaining the development and maintenance of 
psychopathology. 
Experiential avoidance. The Brief Experiential Avoidance Questionnaire (BEAQ;  
(Gámez et al., 2014) refers to efforts to control or avoid unpleasant internal events, such as 
distressing emotions, negative thoughts, or unwanted physical sensations. The BEAQ is a 15-
item measure developed to provide a brief version of the original 62-item Multidimensional 
Experiential Avoidance Questionnaire (Gámez et al., 2011). The BEAQ assesses EA across the 
following domains: behavioral avoidance, distress aversion, suppression, procrastination, 
repression/denial, and distress endurance. Items are rated on a Likert scale ranging from one 
(strongly disagree) to six (strongly agree) and summed to provide a total score, with higher 
scores indicating greater EA (Cronbach’s alpha = .86). The BEAQ has shown convergent 
validity with measures of avoidance, psychopathology, and quality of life as well as discriminant 
validity with measures of negative affectivity and neuroticism (Gámez et al., 2014). The BEAQ 
demonstrates a single factor structure and good internal consistency reliability, with alpha 
coefficients ranging from .80 to .90 across student, clinical and community samples (Della 




Social support.  The Duke-UNC Functional Social Support Questionnaire (FSSQ; 
Broadhead, Gehlbach, De Gruy & Kaplan, 1988; Saracino, Kolva, Rosenfeld & Breitbart, 2015) 
is a 14-item questionnaire evaluating perceived functional social support from one’s social 
network. Items are rated on a Likert scale, ranging from zero (much less than I would like) to 
four (as much as I would like) and summed to provide a total score, with higher scores signifying 
greater perceived social support (Cronbach’s alpha = .91).  
The FSSQ was initially validated in patients recruited from a family medical practice 
(Broadhead et al., 1988), where it had a two-factor structure: affective (i.e., emotional support) 
and confidant support (i.e., the ability to share important information; Broadhead et al., 1988). 
However, recent research validating the scale in populations with advanced or terminal cancer 
supports a one-factor model, with all items loading greater than .60 (Saracino et al., 2015). As 
such, an overall total score was used. The FSSQ has demonstrated good levels of internal 
consistency reliability among chronic illness patients, including those with advanced cancer; 
coefficient alpha ranges from .86 to .94  (Breitbart et al., 2000; Cordova, Cunningham, Carlson, 
& Andrykowski, 2001; Saracino et al., 2015). The measure has also demonstrated good 
convergent validity with measures of social functioning (Broadhead et al., 1988; Mas-Expósito et 
al., 2012; Saracino et al., 2015). 
Trust in physician. The 11-item Trust in Physician Scale (TiPS; Anderson & Dedrick, 
1990) measures patients’ interpersonal trust in their physician. Items are rated on a 5-point Likert 
scale ranging from one (strongly disagree) to five (strongly agree). Scale scores are summed, 
with higher scores reflecting greater trust (Cronbach’s alpha = .84). The scale demonstrates 
strong test-retest reliability and concurrent validity as well as internal consistency, with alpha 




Thom, Ribisl, Stewart, & Luke, 1999). The scale has been used with patients who have a range 
of chronic illnesses, including diabetes (Lee & Lin, 2009), rheumatoid arthritis (Freburger, 
Callahan, Currey & Anderson, 2003), inflammatory bowel disease (Nguyen et al., 2010), and 
cancer (Mainous III et al., 2004). Previous research has demonstrated a one-factor structure 
(Freburger et al., 2003; Thom et al., 1999).   
Emotional distress. Originally designed to assess distress among patients with medical 
conditions, the Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) is a 14-
item self-report tool containing two seven-item subscales: depression and anxiety. Items are 
rated on a four-point Likert scale, ranging from zero to three. Higher scores indicate greater 
symptom severity. Cronbach’s alpha was .85 for the total HADS score, .83 for the anxiety 
subscale, and .78 for the depression subscale. An important reason for using this measure in a 
sample of patients with advanced cancer is that the HADS excludes somatic symptoms of 
depression and anxiety that overlap with medical symptoms (i.e., sleep disturbances, appetite 
fluctuations). A systematic review of the HADS established strong test-retest reliability and 
convergent and discriminant validity. Internal consistency is adequate to high, with alpha 
coefficients ranging from .68 to .93 for the anxiety and .67 to .90 for depression subscale, 
respectively. The review found that correlations between two subscales were only moderate (M = 
.56, range =.40 to.74;  Bjelland et al., 2002). In studies of medically ill individuals, factor 
analyses support a two-factor structure of the HADS (Mykletun, Stordal & Dahl, 2001; Smith et 
al., 2002), which correspond to anhedonia (depression subscale) and autonomic anxiety (anxiety 
subscale). Importantly, the subscales have been shown to be clinically useful in identifying 
depression and anxiety (Smith et al., 2002). The current study uses the two subscales as separate 




(mild symptoms); 11 to 14 (moderate symptoms); and 15 to 21 (severe symptoms; Zigmond & 
Snaith, 1983; Smith et al., 2002). 
Although the HADS is used in oncological settings, the measure was originally normed 
with a primary care population (Zigmond & Snaith, 1983). Previous research has shown that the 
traditional HADS subscale thresholds may be too high for cancer patients, resulting in false 
negatives and an under-recognition of cases (Morse, Kendell & Barton, 2005). Lower threshold 
scores may be more optimal for detecting emotional disorders among cancer patients than the 
norms used for primary care patients (Singer et al., 2009). Specifically, on the HADS depression 
subscale score, anxiety subscale score, and total score, respectively, thresholds of > 2, > 3, and > 
6 allowed for 95% of cases to be detected (sensitivity) and were recommended for clinical 
purposes (Singer et al., 2009). To balance both sensitivity and specificity—that is, the “best 
proportion of sensitivity and specificity,” Singer and colleagues recommended ‘balanced’ cut-
offs of:  > 5, > 7, and > 13 for depression, anxiety, and total scores, respectively (p. 909). These 
cutoff scores will be used for descriptive purposes only and not for analyses. 
 Advanced care planning. The Advanced Care Planning Checklist (ACPC) was 
developed by scientists at MSK to identify key aspects of preparing for end-of-life in preliminary 
research evaluating Meaning-Centered Psychotherapy on advanced care planning outcomes 
(Applebaum, Reisch, Pessin, Rosenfeld & Breitbart, 2017). Psychometric studies for the measure 
are currently underway. The measure contains 13 items assessing whether the patient discussed 
advanced care planning (e.g., prognosis, goals of care, hopes and wishes for the future) with their 
healthcare provider and a loved one, and executed end-of-life directives (i.e., do-not-resuscitate 
orders, designation of health care proxy, designation of power of attorney, and living 




with a healthcare provider or loved one (a total of nine points) and two points for each directive 
they executed (a total of eight points). Thus, the total scores ranged from 0 (absence of any 
discussions with healthcare provider or loved one and no execution of advanced care planning 
directives) to 17 (conversations with both healthcare providers and loved ones, and execution of 
all four directives of advanced care planning). Cronbach’s alpha for the ACPC was .81 in the 
current study.  
 Demographic and medical variables. Data were collected on standard demographic 
variables: race/ethnicity, age, gender, marital status, household income, and education. 
Participants provided information on their cancer, including type of cancer and current stage of 
cancer (III or IV). Participants also indicated whether they previously received counseling or 
treatment for any psychiatric illness or emotional problem. All measures used in the current 
study are provided in Appendix C.  
Data Analyses 
Data analyses occurred in several phases, using the Statistical Package for the Social 
Sciences (SPSS), version 21.0 (SPSS Inc.). First, the predictor and outcome variables were 
examined for systematic patterns of missing values using Little’s Missing Completely at Random 
Test (MCAR). The MCAR test was not significant for any predictor or outcome variables (ps > 
.05), suggesting that data were missing completely at random. As the percentage of missing data 
in main study variables was small (i.e., 4% for EA, 2% for trust in physician, and 1% for social 
support), six participants with missing data were excluded from analyses. Second, descriptive 
statistics (means, standard deviations, ranges, frequencies) of the demographic, medical, 




analyses due to violation of linear regression assumptions, resulting in a final sample of 108 
participants that were used in analyses described below. 
Zero-order Pearson’s correlation coefficients were computed among predictors (IU, EA, 
social support, trust in physician) and outcomes (depression, anxiety, advanced care planning). 
Next, the PROCESS Macro for SPSS (Hayes, 2018) tested the mediation, moderation, and 
moderated mediation hypotheses. Mediation and moderated mediation analyses were run with 
10,000 iterations of bootstrapping. This final phase of data analysis is described below, divided 
into sections pertaining to the psychological outcomes of emotional distress and behavioral 
outcome of advanced care planning, respectively. 
Emotional distress as psychological outcome. The conceptual model in Figure 1 is 
tested in two steps. First, simple mediation models tested whether EA mediates the relationship 
between IU and anxiety and IU and depression. The PROCESS macro generates bootstrapped 
confidence intervals (95% CI) to test the significance of mediation effects (Hayes, 2018). If the 
95% confidence intervals do not contain zero, the point estimate is considered significant at the 
.05 level. Second, four moderated mediation models (also known as conditional process models) 
were computed to test whether the indirect effects of IU on emotional distress via EA were 
contingent on values of the interpersonal factors, social support and trust in physician. The 
mediator (EA) and moderators (social support and trust in physician), variables that define the 
interaction terms, were mean centered prior to analyses using the mean-centering function in the 
PROCESS macro. Although mean-centering does not reduce multicollinearity between the linear 
and interaction terms, it can reduce risk of misinterpreting b1 and b2 coefficients when estimated 




diagrams for these analyses. Unless otherwise reported, regression coefficients are 
unstandardized. 
Hypotheses 1a and 1b. Separate simple mediation analyses were computed for the 
relationships between IU and anxiety symptoms (Figure 3a) and IU and depressive symptoms 
(Figure 3b) with EA as the mediator. Specifically, if the magnitude of the expected positive 
associations between IU and anxiety symptoms (Hypothesis 1a) and IU and depressive 
symptoms (Hypothesis 1b) reduced when EA was added in the model, it would be concluded that 
mediation occurred (Hayes, 2018).  
Hypotheses 2a and 2b. Two second-stage moderated mediation models or conditional 
process models were computed for anxiety symptoms. In Hypotheses 2a and 2b, respectively, 
social support (Figure 4a) and trust in physician (Figure 4b) were tested as moderators of the 
indirect relationship between IU and anxiety symptoms through EA. In other words, for 
participants higher on social support and trust in physician, the mediating influence of EA on the 
association between IU and anxiety would be weaker compared to participants lower on social 
support and trust in physician. 
Hypotheses 3a and 3b. Two second-stage moderated mediation models or conditional 
process models were computed for depressive symptoms. In Hypotheses 3a and 3b, social 
support (Figure 5a) and trust in physician (Figure 5b), respectively, were tested as moderators of 
the indirect relationship between IU and depressive symptoms through EA. Specifically, for 
participants with higher social support and trust in physician, the mediating influence of EA on 
the association between IU and depressive symptoms would be weaker compared to participants 




Advanced care planning as psychological outcome. The conceptual model in Figure 2 
is tested with moderation analyses using the PROCESS macro to examine whether EA 
influenced the strength and direction of the relationship between IU and advanced care planning.  
Hypothesis 4. Participants with both higher IU and EA were hypothesized to engage in 
less advanced care planning as compared to those with higher IU and lower EA (see Figure 6 for 
statistical diagram). The predictor (IU) and moderator (EA) formed the interaction term and were 





















Chapter Four: Results 
Background and Medical Characteristics 
 One hundred and eight participants constituted the study sample. On average, participants 
were 63.0 years old (SD = 11.0). Most were married or partnered (69%), female (53%), primarily 
white (88%) and well-educated (68% had a college degree or higher). Though more than half the 
participants were retired, disabled or on-leave (55%), the majority had a household income of 
$75,000 or greater (66%). Seventeen percent had a previous psychiatric illness for which they 
received treatment; anxiety, depression, or comorbid anxiety and depression were most 
frequently endorsed. The sample included participants with a range of cancers. The most 
common sites were digestive (28%), gynecologic (19%), and thorax (15%). About 30% of the 
participants listed multiple sites and/or reported metastases (i.e., cancer had spread to various 
parts of the body). Approximately 61% of the participants reported that their cancer was Stage 
IV. Complete data on participant characteristics is provided in Table 1. 
Descriptive Statistics for Main Study Variables 
 Descriptive statistics for main study variables, including alpha coefficients for internal 
consistency reliability, are reported in Table 2.  
Levels of emotional distress. According to the original HADS subscale cut-off scores 
(Zigmond & Snaith, 1983), the majority of participants reported mild symptoms of anxiety and 
depression. Specifically, 17 participants (16%) met criteria for mild symptoms of anxiety, 7 
(6.5%) for moderate symptoms, and 3 (3%) for severe symptoms. Similarly, 11 participants 
(10%) met criteria for mild depressive symptoms, 2 (2%) for moderate symptoms, and 1 (1%) 
for severe symptoms. Using the ‘balanced’ cutoff scores recommended for cancer populations 




reported clinically significant depressive symptoms. For descriptive purposes, Singer’s cutoff 
scores and resultant classification percentages are presented along with traditional HADS cutoff 
scores in Table 3.  
Advanced care planning. Table 4 reports frequencies of individual items in the 
advanced care planning measure for descriptive purposes. With respect to advance care 
directives that patients reported executing, designation of healthcare proxy was most frequently 
reported (75%), followed by living will/advanced directive (60%), designation of a power of 
attorney (50%), and DNR order (41%). As noted elsewhere, the measure is used continuously in 
analyses.  
Bivariate Relationships between Background Characteristics and Main Study Variables 
 Bivariate relationships were assessed between participant demographic and medical 
characteristics and the main study variables (see Tables 5 and 6). Income was related to several 
of the main study variables: it had an inverse relationship with EA (r = -.27, p = .007), anxiety (r 
= -.31, p = .002) and depressive symptoms (r = -.38, p < .0001), and was positively associated 
with social support (r = .32, p = .001). Consistent with previous research on patients with 
advanced cancer (Spencer, Nilsson, Wright, Pirl & Prigerson, 2010), females reported greater 
anxiety (M = 6.18, SD = 4.58) than males (M = 4.00, SD = 2.81), t(94.37) = 3.01, p = .003, 
Cohen’s d = .57. Older participants engaged in more advanced care planning (r = .34, p < .0001). 
There were no significant differences between partnered vs. non-partnered participants and those 
with Stage III vs. Stage IV cancers on any of the study variables.   
Bivariate Relationships among Main Study Variables  
As seen in Table 7, the correlations between psychological factors (i.e., IU, EA social 




planning were generally in the expected directions. IU was moderately associated with anxiety (r 
= .40, p < .0001) and depressive symptoms (r = .36, p < .0001 ). EA was positively associated 
with anxiety (r = .28, p = .002) and depressive symptoms (r = .34, p = .000). Furthermore, IU 
and EA were moderately correlated (r = .42, p < .0001). Although the relation between IU and 
advanced care planning was nonsignificant, there was a positive trend (r = .18, p = .06). There 
was no relationship between EA and advanced care planning (r = -.05, p = .62).  
Testing Figure 1: Emotional Distress as the Psychological Outcome  
The mediating role of experiential avoidance. Simple mediation models assessed 
whether the associations between IU and anxiety and IU and depressive symptoms were 
mediated by EA. The analyses for anxiety as the measure of emotional distress were conducted 
first. The same analyses are repeated for depressive symptoms.  
 Anxiety symptoms (Hypothesis 1a). There was a significant positive association between 
IU and EA, as indicated by the regression coefficient (α = .73, SE = .15; 95% CI: .43, 1.02). 
Controlling for IU, the relationship between EA and anxiety symptoms remained significant (b = 
.08, SE = .03; 95% CI: .02, .13). The direct association between IU and anxiety symptoms, 
removing the influence of EA, was significant (c’ = .15, SE = .05; 95% CI: .05, .25). The total 
effect of the model was significant (c = .21, SE = .05; 95% CI: .12, .30). The indirect effect of 
IU on anxiety symptoms was significant (αb = .05, SE = .02; 95% CI: .01, .11). Thus, the data 
appear to support Hypothesis 1a.  
The accompanying completely standardized point estimate of the indirect effect (αbcs = 
.11, SE = .04; 95% CI: .02, .20) is an effect size measure that is standardized and robust against 
small sample sizes (Preacher & Kelley, 2011). According to Kenny (2014), indirect effect size 




considered large. According to these guidelines, the standardized indirect effect of IU on anxiety 
symptoms can be considered a medium effect size. The variance in anxiety symptoms accounted 
for by this model was R2 = .21, F(2,105)=14.0, p < .00001. Table 8 reports the results for direct, 
total and indirect effects of IU on anxiety symptoms. 
 Covariates. Given that women reported more anxiety than men and lower income was 
negatively associated with greater EA and anxiety, the mediation model examining whether there 
was an indirect influence of IU on anxiety symptoms was recomputed with sex and income as 
covariates. This analysis was conducted with the 98 participants who provided data on their 
income. The direct (c’ = .14, SE = .05; 95% CI: .04, .23) and the indirect influence of IU through 
EA remained significant (αb = .05, SE = .02; 95% CI: .01, .10), even when sex and income were 
covaried. The total effect of the model was significant (c = .19, SE = .05; 95% CI: .10, .28). The 
accompanying completely standardized point estimate of the indirect effect (αbcs  
= .10, SE = .04; 95% CI: .02, .18) indicated a medium effect size (Preacher & Kelley, 2011). The 
variance in anxiety symptoms accounted for by this model was R2 = .34, F(4,93)=11.8, p < 
.0001. The full results for direct, total and indirect effects of IU on anxiety symptoms, with sex 
and income covaried can be found in Table 8. 
 Depressive symptoms (Hypothesis 1b). As noted above, there was a significant 
relationship between IU and EA (α = .73, SE = .15; 95% CI: .43, 1.02). Controlling for IU, the 
relationship between EA and depressive symptoms was significant (b = .07, SE = .02 ; 95% CI: 
.02, .11). The direct relationship between IU and depressive symptoms, removing the influence 
of EA, was significant (c’ = .10, SE = .04; 95% CI: .02, .18). The total effect of the model was 




symptoms through EA was also significant (αb = .05, SE = .01; 95% CI: .004, .03). Thus, 
Hypothesis 1b was supported.  
 The completely standardized point estimate of the indirect effect (αbcs = .11, SE = .05; 
95% CI: .03, .22) demonstrates a medium effect size (Kenny, 2014). The variance in depressive 
symptoms accounted for by this model was R2 = .19, F(2,105)=12.22, p < .00001. Table 9 
presents the results for direct, total and indirect effects of IU on depressive symptoms.  
Covariates. Similar to the mediation model of anxiety, the mediation model examining 
whether there was an indirect influence of IU on depressive symptoms was recomputed with sex 
and income as covariates (n = 98). The direct effect of IU (c’ = .09, SE = .04; 95% CI: .003, .17) 
and the indirect effect of IU through EA remained significant (αb = .04, SE = .04; 95% CI: .003, 
.17), even when sex and income were covaried. The accompanying completely standardized 
point estimate of the indirect effect (αbcs = .10, SE = .05; 95% CI: .01, .20) indicated a medium 
effect size (Preacher & Kelley, 2011). The total effect of the model was significant (c = .13, SE = 
.04; 95% CI: .05, .20). The variance in depressive symptoms accounted for by this model was R2 
= .27, F(4,93)=8.67, p < .00001. The full results for direct, total and indirect effects of IU on 
depressive symptoms, with sex and income covaried, can be found in Table 9.  
In sum, the simple mediation analyses suggested both a direct influence of IU on anxiety 
and depressive symptoms and an indirect influence through EA. These findings remained 
significant even when sex and income were covaried.   
Conditional indirect effects as a function of interpersonal factors. The finding that 
EA may play a mediating role in the relationship between IU and anxiety and IU and depressive 
symptoms does not preclude the possibility that these indirect effects are conditional on some 




physicians were tested as moderators of the indirect relationship between IU and emotional 
distress through EA.  
 Anxiety symptoms. The indirect influence of IU on anxiety symptoms through EA was 
hypothesized to be weaker for participants with greater social support and trust in physician as 
compared to those with lower social support and trust in physician. Two second stage moderated 
mediation models tested these hypotheses.  
 Social support as moderator (Hypothesis 2a). The model tested whether EA, as the 
mechanism through which IU influences anxiety symptoms, was contingent on the extent to 
which participants felt supported by their social network. The index of moderated mediation, 
which quantifies the relationship between the moderator and the indirect effect, was not 
significant (αb3 = -.003, SE = .002, 95% CI: -.004, .003). Controlling for the influence of IU and 
EA on anxiety symptoms, the interaction term of EA x social support was not significant (b3 = 
.0003, SE = .002; 95% CI: -.01, .004). Thus, the indirect influence of IU on anxiety through EA 
was not a function of social support and Hypothesis 2a was not supported. Holding EA, social 
support and the interaction term constant, the direct relationship between IU and anxiety 
symptoms remained significant (c’ = .12, SE = .05; 95% CI: .03, .22). The total variance 
explained by the model was R2 = .22, F(4, 103) = 7.37, p < .0001. In sum, although there was a 
direct association between IU and anxiety symptoms, no conditional indirect effects of IU by 
social support were observed and the model was not interpreted further.  
 Covariates. Even though Hypothesis 2a was not significant, social support may influence 
anxiety symptoms when the influence of income and sex is removed. The model was recomputed 




the indirect relationship between IU and anxiety through EA even when income and sex were 
controlled (see Appendix D).  
 Trust in physician as moderator (Hypothesis 2b). The model tested whether EA, as the 
mechanism through which IU influences anxiety symptoms, was contingent on the extent to 
which participants felt trust in their physician. The index of moderated mediation was significant 
(αb3 = .01, SE = .004, 95% CI: .003, .02). Controlling for the influence of IU and EA on anxiety 
symptoms, the interaction term of EA x trust in physician was significant (b3 = .01, SE = .005, 
95% CI: .003, .02). As the indirect influence of IU on anxiety symptoms through EA was a 
function of trust in physician, the conditional indirect effect of IU on anxiety was examined at 
three values of patients’ trust in physician: one standard deviation below the mean (low trust in 
physician), the mean (average trust in physician), and one standard deviation above the mean 
(high trust in physician; Aiken & West, 1991; Hayes, 2018). Contrary to Hypothesis 2b, although 
there was a conditional indirect influence of IU (through EA), it was only observed at average or 
high levels of trust in physician, not low levels (see Figure 7).  Holding EA, trust in physician, 
and the interaction term constant, the direct relationship between IU and anxiety symptoms 
remained significant (c’ = .18, SE = .05; 95% CI: .08, .27). The total variance explained by the 
model was R2 = .26, F(4, 103) = 9.07, p < .0001.  
 Although there was a direct relationship between IU and anxiety, the indirect influence of 
IU on anxiety was conditional on patients’ trust in physician. However, it was not in the 
predicted direction: Among participants with average to high levels of trust in physician, the 
indirect positive association between IU and anxiety through EA was significant. There were no 
indirect effects at low levels of trust in physician. Table 10 reports the full regression results for 




Covariates. Given that women reported more anxiety than men and lower income was 
negatively associated with greater EA, anxiety, and depressive symptoms, the moderated 
mediation model examining whether there were conditional indirect effects of IU on anxiety by 
trust in physician was recomputed with gender and income as covariates. The analysis was 
conducted with the 98 participants who provided income data. Controlling for the influence of 
IU, EA, gender, and income on anxiety symptoms, the index of moderated mediation, which 
quantifies the relationship between the moderator and the indirect effect remained significant 
(αb3 = .01, SE = .005, 95% CI: .004, .02). The interaction term of EA x trust also remained 
significant (b3 = .02, SE = .005, 95% CI: .006, .03) and is graphed in Figure 8.  
The findings mirrored those without covariates. Although there was a conditional indirect 
influence of IU (through EA), contrary to Hypothesis 2b, it was only observed at high levels of 
trust in physician, not low or average levels.  Holding EA, trust in physician, gender, income, 
and the interaction term constant, the direct relationship between IU and anxiety symptoms 
remained significant (c’ = .17, SE = .05; 95% CI: .07, .26). The total variance explained by the 
model was R2 = .41, F(6, 91) = 10.61, p < .0001. Table 11 reports the full regression results for 
the conditional indirect effects of this model.  
 Depressive symptoms. Similar to the hypotheses for anxiety, the indirect influence of IU 
on depressive symptoms through EA was hypothesized to be weaker for participants with greater 
social support and trust in physician as compared to those with lower social support and trust in 
physician. Two moderated mediation models tested these hypotheses. 
 Social support as moderator (Hypothesis 3a). This model tested whether the potential 
mediating role of EA in the relationship between IU depressive symptoms was contingent on the 




of IU and EA on depressive symptoms, the interaction term of EA x social support was not 
significant (b3 = .001, SE = .002; 95% CI: -.003, .005), nor was the index of moderated 
mediation (αb3 = .001, SE =   .002, 95% CI: -.004, .003). As the relationship between IU and 
depressive symptoms through EA was not a function of social support, Hypothesis 3a was not 
supported. Holding EA, social support, and the interaction term constant, the direct association 
between IU and depressive symptoms remained significant (c’ = .09, SE = .04; 95% CI: .08, 
.17). The total variance explained by the model was R2 = .21, F(4, 103) = 6.80, p = .0001. 
Although there was a direct relationship between IU and depressive symptoms, no conditional 
indirect effects of IU by social support were observed and the model was not interpreted further.   
Covariate. The same analysis was recomputed with income as a covariate (n = 98). Sex 
was not included as a covariate because it was not associated with depressive symptoms. No 
conditional indirect effects of IU on depressive symptoms as a function of social support were 
observed (Appendix E).  
Trust in physician as moderator (Hypothesis 3b). This moderated mediation model tested 
whether the mediating role of EA in the relationship between IU and depressive symptoms was 
contingent on the extent to which participants felt trust in their physician. Controlling for the 
influence of IU and EA on depressive symptoms, the interaction term of EA x patients’ trust in 
physician was not significant (b3 = .002, SE =.004; 95% CI: -.007, .01). Further, the index of 
moderated mediation, which quantifies the relationship between the moderator and the indirect 
effect, was not significant (αb3 = .001, SE = .004, 95% CI: -.006, .009). As an indirect 
association between IU and depressive symptoms through EA was not a function of trust in 
physician, Hypothesis 3b was not supported. Holding EA, trust in physician, and the interaction 




(c’ = .10, SE = .04; 95% CI: .02, .18). The total variance explained by the model was R2 = .19, 
F(4, 103) = 6.16, p = .0002. In other words, though there was a direct relationship between IU 
and depressive symptoms, no conditional indirect effects of IU by trust in physician were 
observed and the model was not interpreted further.   
Covariate. The analysis was recomputed with income as a covariate (n = 98). Sex was 
not included as a covariate because it was not associated with depressive symptoms. No 
conditional indirect effects of IU on depressive symptoms as a function of trust in physician were 
found (Appendix F).  
Moderation Model with Advanced Care Planning as Behavioral Outcome 
As shown in Figure 2, EA was hypothesized to moderate the relationship between IU and 
advanced care planning. Specifically, participants who were high on IU and high on EA were 
expected to engage in less advanced care planning as compared to participants who were high on 
IU and low on EA.   
The moderating role of EA (Hypothesis 4). Simple moderation analysis was used to 
test whether EA moderated the relationship between IU and advanced care planning. As no 
interaction between IU and EA was found (b3 = -.003, SE: .004; 95% CI: -.01, .004), Hypothesis 
4 was not supported. Holding IU and the interaction term constant, there was no observed 
relationship between EA and advanced care planning (b2 = -.05, SE = .04; 95% CI: -.12, .02). 
However, there was a direct influence of IU. Controlling for EA, participants with greater IU 
engaged in more advanced care planning (c’ = .16, SE = .06; 95% CI: .03, .28). The total 
variance in advanced care planning explained by the model was nonsignificant, R2 = .06, F(3, 




Covariate. As age was significantly positively associated with advanced care planning, 
the moderation model was recomputed with age as a covariate. The pattern of results remained 
the same; EA did not moderate the association between IU and advanced care planning 
(Appendix G). 






















Chapter Five: Alternative Models 
As the data are cross-sectional and intended to inform future causal models, alternative 
models were tested in post-hoc analyses. In post-hoc analyses for emotional distress, gender and 
income were included as covariates and, consequently, the sample size for these analyses was 98 
participants.  
Emotional Distress as Psychological Outcome 
Alternative 1: First stage moderated mediation. Four ‘first stage’ moderated mediation 
models were tested as alternative models in post-hoc analyses. Two were computed with anxiety 
as the outcome and two with depressive symptoms. For both outcomes, support and trust in 
physician were moderators. In these alternative models, the moderator variables of social support 
and trust in physician were proposed to act on the relationship between IU and EA (and not EA 
and distress, as in Figure 1) for both anxiety and depressive symptoms. This alternative 
conceptual model is depicted in Figure 9.  
Anxiety. The possibilities that the indirect relationship between IU on anxiety through 
EA was moderated by social support and trust in physician in the first stage were examined. For 
example, among those with greater social support and trust in physician, there may be a smaller 
positive association between IU on EA, compared to those with lower social support and trust in 
physician. In post-hoc analyses 5a and 5b, the indices of moderated mediation suggested that 
indirect effect of IU was not contingent on social support (αb3 = .00, SE = .001, 95% CI: -.002, 
.002) or trust in physician (αb3 = .001, SE = .003, 95% CI: -.01, .004), and the model was not 
interpreted further. 
Depressive symptoms. In post-hoc analyses 6a and 6b, the possibility that the indirect 




by social support and trust in physician, respectively, was also explored. Similar to the results for 
anxiety, the indirect association between IU and depressive symptoms through EA was not a 
function of social support (αb3 = .00, SE = .001, 95% CI: -.002, .002) or trust in physician (αb3 = 
.001, SE = .002, 95% CI: -.005, .003), and the models were not interpreted further.  
Alternative 2: Switching the mediator with the moderators. It is conceivable that the 
relationships between IU and indices of emotional distress are mediated by social support and 
trust in physician and that these indirect relationships are moderated by EA. Figure 10 depicts the 
conceptual moderated multiple mediation model for this post-hoc analysis. This model is known 
as the differential dominance conditional process model, as it allows for different mechanisms to 
be dominant for different types of people, defined by their position on the moderator (Hayes, 
2019, personal communication).  
Anxiety. In post-hoc analysis 7, the possibility that the indirect relationships between IU 
and anxiety through social support (mediator 1) and trust in physician (mediator 2) were 
contingent on the extent to which participants engaged in EA was explored. The statistical 
diagram of this model is depicted in Figure 11. Indices of moderated mediation indicated that the 
indirect role of IU through social support was not moderated by EA (α1b4 = -.0001, SE = -.001, 
95% CI: -.002, .002), but the indirect influence of IU on anxiety through trust in physician was 
contingent on EA (α2b5 = -.003, SE = .001, 95% CI: -.01, -.0004). Controlling for the influence 
of IU, social support, trust in physician, EA, sex, income, and the interaction term of EA x social 
support, the interaction term of EA x trust in physician was significant (b4 = .01, SE = .005, 95% 
CI: .005, .03).  
As the interaction term was significant, the conditional indirect effect of IU on anxiety 




mean (average EA), and one standard deviation above the mean (high EA). Although there was a 
conditional indirect effect of IU through trust in physician, it was only observed at high levels of 
EA (see Figure 12).  Holding all other variables constant, the direct relationship between IU and 
anxiety symptoms remained significant (c’ = .16, SE = .05; 95% CI: .06, .25). The total variance 
explained by the model was R2 = .42, F(8, 89) = 8.06, p < .0001.  
In sum, for this alternative model, there were both a direct and indirect relationships 
between IU and anxiety symptoms. The indirect influence of IU on anxiety through patients’ 
trust in physician was a function of EA: Higher IU was related to greater anxiety operating 
through higher levels of trust in physician but only among participants with high EA, not low or 
average EA. There was no conditional indirect influence of IU on anxiety through social support 
by EA. These findings are reflected in Table 14, which reports the full results of this second 
stage multiple moderated mediation.  
Depressive symptoms. In post-hoc analysis 8a, a second stage multiple moderated 
mediation was also tested with depressive symptoms as the outcome. However, indices of 
moderated mediation suggested that the possible indirect influence of IU on depressive 
symptoms through the mechanisms of social support (α1b4 = -.0003, SE = .001, 95% CI: -.002, 
.002), and trust in physician (α2b5 = -.001, SE = .001, 95% CI: -.003, .001) were not conditional 
on any value of the moderator EA and the model was not examined further.  
Hayes (2018) recommends testing simpler mediation models when moderated mediation 
models do not apply. In post-hoc analysis 8b, a parallel mediation model (without the moderator) 
was computed to examine whether the relationship between IU and depressive symptoms was 
mediated by social support (mediator 1) and trust in physician (mediator 2). Neither the indirect 




.01, .04), nor trust in physician were significant (αb2cs = .01, SE = .01; 95% CI: -.01, .04); 
however, the direct relationship between IU and depressive symptoms remained significant (c’ = 
.10, SE = .04; 95% CI: .03, .18). The statistical diagram for this parallel mediation model (post-
hoc analysis 8b) is presented with path coefficients and standard errors in Appendix F.   
Summary. Four first-stage moderated mediation models were computed to test the 
conceivable possibility that moderation of the indirect effect (via social support and trust in 
physician) was occurring on the association between IU and EA rather than EA and emotional 
distress (Post-hoc analyses 5a, 5b, 6a, 6b). First-stage moderated mediation for anxiety or 
depressive symptoms was not supported and, as such, lends support to the main results.  
Post-hoc analysis 7 explored a different alternative model; specifically, the analysis tested 
whether the potential indirect relationship between IU and anxiety through social support 
(mediator 1) and trust in physician (mediator 2) was contingent on EA. Multiple moderated 
mediation was partially supported and the results indicated that only among participants highest 
on EA did the indirect relationship between IU and anxiety through trust in physician remain 
significant. Notably, the index of moderated mediation for this effect was much smaller (α2b5 = -
.003) than what was found in the comparable model in the main study Hypothesis 2b (αb3 = .01). 
Conversely, there was no conditional indirect influence of IU on anxiety through social support 
as a function of EA.    
Post-hoc analysis 8 was identical to post-hoc analysis 7, except that depressive symptoms 
was the outcome. There were no conditional indirect effects of IU on depressive symptoms 
through social support (mediator 1) or trust in physician (mediator) as a function of EA. Because 




was tested (Hayes, 2018), with social support and trust in physician as mediators of the 
relationship between IU and depressive symptoms. No parallel mediation effects were found. 
Advanced Care Planning as Behavioral Outcome 
 Although EA did not moderate the association between IU and advanced care planning, 
there was a direct relationship between IU and advanced care planning. As a result, a three-step 
hierarchical multiple regression analysis with advanced care planning was conducted in post-hoc 
analysis 9 to test whether the influence of IU and EA remained significant after other empirically 
and theoretically relevant factors were controlled. The sample size for this analysis was 108 
participants. 
 Hierarchical multiple regression.  On the first step, age and a summed score of 
emotional distress (control variables) were entered. Age was included as it was found to be 
moderately correlated with advanced care planning (r = .34, p < .0001). The total score for 
emotional distress was entered as opposed to the individual anxiety and depressive symptoms 
subscales to conserve power. On the next step, the interpersonal factors of social support and 
trust in physician were entered and, on the final step, the intrapersonal factors of IU and EA were 
entered. Intercorrelations between these variables were reported in Table 7. The hierarchical 
multiple regression statistics summarized below are reported in Table 15.  
 At Step 1, age and emotional distress contributed significantly to the regression model 
F(2, 105) = 7.09, p = .001, accounting for 12% of the variance in advanced care planning. The 
addition of interpersonal factors, social support and trust in physician in Step 2 added 0.1% 
variance, which did not significantly contribute to the model, F(2, 103) = .07, p = .93. Finally, in 
Step 3, the addition of the intrapersonal factors, IU and EA, explained 5% additional variance in 




variables were included in Step 3 of the hierarchical regression model, only age (B = .14; t = 
3.81, p < .0001) and EA  (B = -.07; t = -2.01, p = .046) contributed significantly to the model, 
while IU approached significance (B = .12; t = 1.97, p = .05). The six variables together 
accounted for 17% of the variance in advanced care planning.  
 Summary. In post-hoc analysis 9, a three-step hierarchical regression model tested 
whether the relationship between IU and advanced care planning remained significant after 
controlling for the influence of age, emotional distress, interpersonal variables (social support 
and trust in physician) and an intrapersonal variables (EA). At the final hierarchical regression 
step, age remained the strongest significant predictor, followed by EA. Participants who were 
older were more likely to engage in advanced care planning. As well, greater EA was 
significantly related to less advanced care planning. The relationship between IU and advanced 
care planning approached significance, such that participants with greater IU engaged in more 
advanced care planning.  
 All main study hypotheses (chapter three) as well as the post-hoc analyses presented in 
this chapter for emotional distress and advanced care planning along with the result (i.e., 











Chapter Six: Discussion 
 “Illness is the nightside of life. Everyone who is born holds dual citizenship, in the kingdom of 
the well and in the kingdom of the sick.” ~ Susan Sontag 
  The context of advanced cancer is fraught with situational uncertainty. At times, patients 
may have the experience of navigating in the dark as they traverse myriad illness-related 
stressors, such as concerns about prognosis, treatment options, physical symptoms, and death and 
dying (Cheng, Lo, Chan, Kwan, & Woo, 2010; Reinke et al., 2008). At its core, the construct of 
intolerance of uncertainty (IU) involves a dispositional fear of the unknown (Carleton, 2016). 
Those with high IU have a reduced capacity to tolerate the aversive internal reactions prompted 
by situations presenting a lack of key information or the possibility of future negative events.  
Most commonly studied as an etiological, transdiagnostic factor in individuals with 
psychological disorders (Rosser, 2019), such as generalized anxiety, IU may also be relevant for 
patients with advanced cancer who are experiencing symptoms of distress. Although the IU-
distress link is well-established in psychopathology research (Gentes & Ruscio, 2011), 
mechanisms and moderators of this relationship deserve further exploration both at-large and in 
the area of advanced disease so as to develop efficacious psychosocial interventions.   
Based on Lepore (2001)’s social cognitive processing framework of adjustment to cancer, 
the conceptual model in Figure 1 proposed a moderated mediation model that included both 
intrapersonal and interpersonal factors to explain emotional distress among advanced (Stage III 
or IV) cancer patients. To identify mechanisms underlying the IU—distress relationship, an 
intrapersonal mediator, experiential avoidance (EA), was proposed. In addition, the indirect 
relationship between IU and distress through EA was hypothesized to be weaker for individuals 




The dissertation findings provide mixed support for the conceptual model. As 
hypothesized, the results provide strong support for the idea that IU has both direct and indirect 
relationships (through EA) with anxiety and depressive symptoms. The hypotheses regarding 
moderation of this mediational pathway yielded more complex and unexpected findings. The 
indirect influence of IU on depressive symptoms through EA was not moderated by patients’ 
perceived availability of social support or trust in physician, nor was the indirect influence of IU 
on anxiety symptoms a function of perceived support. There was, however, a moderating 
influence of trust in physician on anxiety, albeit in an unexpected direction: The indirect 
relationship between IU and anxiety through EA was significant for patients with higher levels 
of trust in physician than those with lower trust.  
An Intrapersonal Mechanism Underlying the IU-Distress Relationship 
The primary finding of the study was not simply that the dispositional factor of IU was 
related to greater anxiety and depressive symptoms but that EA is a potentially powerful 
mechanism underlying this relationship. Patients with advanced cancer who have a low threshold 
for tolerating uncertainty may experience difficulty regulating their internal milieu. These 
individuals likely engage in EA—that is, repeated cognitive, affective or behavioral attempts to 
avoid negative thoughts, emotions, bodily sensations, memories or images (Hayes et al., 1996). 
Although the goal of these attempts is to decrease or escape distress, continuous habitual efforts 
to avoid these internal experiences can paradoxically increase distress and perpetuate reactivity 
(Hayes et al., 2012). IU and EA have previously been shown to be independent contributors to 
anxiety (Buhr & Dugas, 2012) and depression (Crib, Moulds, Carter, 2006; Jensen, Cohen, 




IU-distress relationship (e.g., Lee et al., 2010), and this is the first study to examine these factors 
with patients who have advanced cancer.  
Keeping the person x situation interactionist framework in mind (Mishel, 1990), consider 
the following scenario: Benni has metastatic cancer and also tends to find the possibility of 
future negative events occurring intolerable. This cognitive filter might interact with the 
situational uncertainty associated with advanced illness to affect his subsequent cognitive, 
emotional, and behavioral responses. To manage his [understandable] intrusive thoughts (e.g., 
“What if this treatment doesn’t work? How much time do I have left? What if I die before I am 
ready?”), Benni may engage in EA (“I shouldn’t think about treatment not working. I am not 
going to feel anxious about how much time I have left. I don’t want to get depressed by thinking 
about dying”). Humans are verbal creatures; in trying to avoid his thoughts and emotions, Benni 
is forming verbal rules that contain the very stimuli he desires to escape (Boulanger, Hayes, & 
Pistorello, 2010). Consequently, although EA may provide short-term relief, repeated efforts to 
deny internal experiences are likely to result in subsequent psychological and physiological 
reactivity, and are indicative of psychological inflexibility (Kashdan, Barrios, Forsyth, & Steger, 
2006; Lepore, 2001; Tull, Jakupcak, & Roemer; 2010). 
The findings regarding EA as a mediator of the IU-distress relationship are in line with 
cognitive processing theories of adjustment suggesting that stressful experiences such as 
advanced cancer challenge individuals’ view of themselves and the world (Horowitz, 1986). 
Successful adaptation involves integration of cancer-related events or stress into existing mental 
models through cognitive processing, emotional expression and acceptance rather than EA 
(Lepore, Silver, Wortman, & Wayment, 1996; Rost et al., 2012). As such, EA may be a prime 




The Interpersonal Context: Social Support and Trust in Physician 
 According to the social-cognitive framework of emotional adjustment to cancer, 
cognitive processing occurs in a social context (Lepore, 2001). For patients with advanced 
cancer, relationships with loved ones (friends and family) and formal caregivers (healthcare 
providers) have the potential to provide support or act as stress buffers. In this study, perceived 
social support did not moderate the indirect relationship between IU and indices of emotional 
distress. Similarly, trust in physician did not exert a buffering influence on the relationship 
between IU and depressive symptoms; however, it did moderate the relationship between IU and 
anxiety symptoms. 
Why did trust in physician appear to exacerbate rather than buffer anxiety? 
Contrary to the hypothesis that trust in physician would play a protective role, among those with 
average or high levels of trust, the indirect relationship between IU and anxiety through EA was 
stronger rather than weaker; there was no indirect effect of IU on anxiety when patients reported 
low trust in physician. After controlling for sex and income, this pattern of results changed only 
slightly: Among those with high levels of trust in physician, there was an influence of IU on 
anxiety through EA but not at low or average trust in physician. Rather than the hypothesized 
buffering effect, there appeared to be an exacerbating influence of trust in physician on the 
relationship between IU and anxiety. This surprising finding bears further consideration.  
One possible explanation is that among patients with high trust in physician, the inability 
to tolerate the possibility of future negative events occurring is related to greater EA  and, 
consequently, higher symptoms of anxiety. In the context of advanced cancer, medical 
professionals themselves do not have complete certainty about prognosis, survival rates or the 




much time do I have left?” If a patient with advanced cancer is highly intolerant of uncertainty, 
they may interpret vague information or the absence of key information (e.g., their chances of 
survival) from a trusted physician as highly aversive and engage in EA rather than stay in contact 
with the negative internal events induced by the perception of uncertainty. Yet another 
explanation may be that among those who are more intolerant of uncertainty and high on trust in 
physician, patients are more likely to engage in EA through strategies such as reassurance-
seeking. Reassurance-seeking is conceptualized as a safety-seeking avoidance behavior observed 
in individuals with various types of anxiety, including illness—or health—related anxiety and, 
ultimately, serves to maintain or increase anxiety (Stark et al., 2004; Tang et al., 2007). 
Alternatively, some patients with high trust may simply prefer to not know details or refrain from 
asking many questions of their physician, facilitating the indirect influence of IU on anxiety 
through EA. 
An alternative post-hoc analysis, which involved switching the mediator with the 
moderators, was also conducted. In the alternative model, the association between IU and 
distress was proposed as operating through trust in physician (mediator) and contingent on level 
of EA (moderator). Though the conditional indirect effect was bigger in the original model 
(where EA is the mediator and trust in physician the moderator; Figure 1), the indirect influence 
of IU via trust in physician was found to be a function of EA. Only among patients with 
advanced cancer who had high EA (compared to low or average EA), was there a significant 
positive association between trust in physician and anxiety. This finding may be indicative of 
patients high on EA externalizing the locus of control to powerful others, such as their physician.  
Shifting control to powerful others has been shown to predict greater trust in physician 




may be more pronounced among patients who perceive their condition to be severe (Berrios-
Rivera et al., 2006; Shenolikar, Balkrishnan, & Hall, 2004). Attributing control to an external 
agent, in this case, a medical expert, might facilitate avoidance (Arraras, Wright, Jusue, Tejedor, 
& Calvo, 2002; Sharif & Khanekharab, 2017) and has been related to greater distress (Brown et 
al., 2015; Mystakidou, Tsilika, Parpa, & Galanos, 2014). In contrast, approach strategies, such as 
emotional expression or acceptance, have been related to lower distress in both advanced (Nipp 
et al., 2016) and early-stage cancer patients (Stanton et al., 2000).  
Taken together, the results of the original conceptual model (Figure 1) and the alternative 
post-hoc analysis (Figure 10) suggest a feedback loop for individuals with advanced cancer who 
are intolerant of uncertainty. Greater EA facilitates more trust in their physician as a way to 
externalize control; however, any uncertain or negative information provided by the ‘trusted’ 
physician regarding the cancer (i.e., prognosis) may result in more use of EA. For these patients, 
externalizing control (as indicated by trust in physician) and engaging in EA may be part of a 
recursive process that ultimately increases anxiety because the patients are unwilling to stay in 
contact with their intrusive thoughts and negative emotions, making it difficult to establish 
internal equilibrium.  
Why did trust in physician have no influence on depressive symptoms? Unlike 
anxiety, the indirect influence of IU on depressive symptoms was not moderated by trust in 
physician. In large part, this finding could be a result of the very restricted range in depressive 
symptoms. Although prevalence of both anxiety and depressive symptoms were low, the average 
depressive symptoms score was even lower than anxiety and there may not have been enough 




Further, there is some evidence that physicians’ communication style affects anxiety 
more so than negative mood. In a recent experimental study comparing cancer patients and 
community participants who did not have cancer, an empathetic communication style by the 
physician predicted greater trust in physician and lower anxiety but was unrelated to negative 
affect among both groups of participants (Zwingmann, Baile, Schmier, Bernhard, & Keller, 
2017). Even if greater trust in physician has been shown to reduce anxiety, it may not protect 
against feelings of deep sorrow or sadness, particularly if a patient with advanced cancer has 
prognostic awareness or understanding of their imminent death.  
The absence of social support effects. Although the perceived availability of social 
support has been found to buffer against the negative effects of life events or stress on adaptation 
to many illnesses (Wills & Ainette, 2012; Uchino, 2009), the indirect relationship between IU 
and emotional distress through EA was not moderated by social support. There may be a few 
possibilities for this finding. Assessing unhelpful social interactions as they relate to 
psychopathology or emotional distress (Figueiredo, Fries & Ingram, 2004; Lepore & Revenson, 
2007) may be more important than perceived availability of support (Pagel, Erdly & Becker, 
1987). Neither negative social interactions nor problematic support was assessed in the current 
study. Consequently, even if participants believed they could obtain emotional and functional 
support from their network, this information does not speak to the quality of supportive 
interactions nor does it preclude the possibility of negative social interactions within close 
relationships (Schuster, Kessler, & Aseline, Jr., 1990).  
 Social constraints are one way to assess negative social interactions (Lepore & 
Revenson, 2007). Social constraints are perceived or spoken words or perceived or received 




concerns about a stressor. Ultimately, social constraints limit disclosure and processing of 
cancer-related events, and impede adjustment (Adams, Winger & Mosher, 2015). Negative 
social interactions have been shown to be stronger predictors of emotional well-being than 
positive social interactions (Coyne & Anderson, 1999; Revenson, Schiaffino, Majerovitz, & 
Gibofsky, 1991; Rivers & Sandford, 2018). The mobilization-minimization hypothesis posits that 
compared to positive events (e.g., supportive interactions), negative events (e.g., negative 
interactions) incite more powerful and proximate affective, cognitive, and behavioral responses 
(Taylor, 1991). For example, among women with metastatic breast cancer, problematic support 
was positively and strongly related to mood; perceptions of positive or helpful social support 
were unrelated to mood and did not have moderating effects (Koopman et al., 1998). 
In the current study, anxiety and depression were tested as psychological outcomes. 
However, perceived support may be more relevant for indices of positive rather than negative 
affect or mood (e.g., Benedict et al., 2015). Positive and negative mood have been previously 
described as constructs that independently influence emotional wellbeing and even co-occur 
when individuals are managing a chronic stressor (Folkman & Moskowitz, 2000). Social support 
is a nuanced construct and can be assessed and analyzed in multiple ways. Perceived support 
alone may not accurately capture the complexity of social relationships in the context of 
adjustment to illness (Carpenter et al., 2010; Taylor, 2011). Although perceptions regarding the 
availability of support did not appear to have a protective influence on relationship between IU 
and emotional distress in this sample, a more thorough investigation assessing types and sources 
of support, satisfaction with support, receipt of support, and number of people in the patients’ 




Low rates of anxiety and depressive symptoms. One reason for the lack of empirical 
support for some of the moderated mediation hypotheses (e.g., social support buffering the 
indirect relationship between IU on emotional distress) may be the remarkably low rates of 
emotional distress reported by study participants and, thus, the small amount of variance in 
emotional distress to explain the full conceptual model. Approximately 9% of participants in the 
sample reported clinically significant anxiety symptoms and another 16% reported subclinical 
symptoms. Only 3% percent of the sample reported clinically significant depressive symptoms 
and an additional 10% reported subclinical symptoms. These very low rates of emotional distress 
are inconsistent with data from systematic reviews, meta-analyses, and large studies (Carlson et 
al., 2018; Krebber et al., 2014; Mitchell et al., 2011). One meta-analytic review assessing the 
prevalence of emotional disorders in cancer patients across palliative, oncological and 
hematological settings using thorough, strict interview-based criteria (i.e., Diagnostic and 
Statistical Manual of Mental Disorders or International Classification of Diseases) found that the 
prevalence of adjustment disorder was highest (~15%), followed by major depression (~14%) 
and anxiety (~10%; Mitchell et al., 2011).  
Given that the vast majority of chronic illness patients do not meet full diagnostic criteria 
for emotional disorders, refraining from pathologizing all individuals with cancer is important 
(Hoyt & Stanton, 2012). However, as indicated by the review papers cited above, rates of 
clinically significant emotional distress in the advanced cancer population appear higher than 
those reported by the current sample. A publication bias is possible as research with smaller 
samples finding low rates of emotional distress (comparable to the current sample) may have 




depressive symptoms reported by the current sample may have also been found in other 
unpublished research on patients with advanced cancer.  
There is also debate about the utility of the Hospital Anxiety and Depression Scale 
(HADS), the emotional distress measure used in the current study, as an assessment tool for 
accurately evaluating emotional distress in patients with [advanced] cancer. Although the HADS 
is commonly used in oncological settings (Wakefield et al., 2015), it may perform better when 
the disease is stable rather than advanced (Ibbotson, Maguire, Selby, Priestman, & Wallace, 
1994); moreover, the HADS anxiety subscale may perform better than the depression subscale in 
advanced cancer populations (Hopwood, Howell, & Maguire, 1991). A recent meta-review of 11 
reviews in depression screening in oncology that assessed more than 50 depression instruments 
found that the accuracy of the HADS is moderate at best (Wakefield et al., 2015).  
In the current study, anxiety and depressive symptom cutoffs were used for descriptive 
rather than analytic purposes because of power issues. However, some research suggests that the 
standard HADS cutoff scores may be too high for cancer patients, which can result in false 
negatives (Morse et al., 2005). Singer et al. (2009) suggested the following cutoffs to balance 
sensitivity with specificity for cancer populations: > 7 for anxiety and > 5 for depression. 
Applying these thresholds to the current sample, 32% met criteria for clinically significant 
anxiety and 31% for depressive symptoms (Table 3). Summarily, the evidence reviewed here 
suggests that the HADS underestimates the presence of emotional distress in patients with 
advanced cancer. In-depth interview-based assessment would address this issue and help detect 
both false negatives and positives (Mitchell et al., 2011). Such assessments can take more time, 
require additional funds, and contribute to patient burden, with the latter being a major concern 




The Role of Intrapersonal Factors in Advanced Care Planning 
The study also covered new ground in examining the roles of intrapersonal and 
interpersonal factors in advanced care planning among individuals with Stage III and IV cancers. 
Advance care planning refers to the process through which patients, along with their families and 
health professionals, discuss and establish directives around medical and palliative care in 
accordance with the patient's values and preferences. The overarching goal of advanced care 
planning is to support patients in receiving the care they would have chosen should they become 
too unwell to make end-of-life decisions (Johnson et al., 2016). EA was proposed as a moderator 
of the relationship between IU and advanced care planning, such that among patients higher on 
EA (versus lower), IU would be related to more advanced care planning. Although the 
relationship between IU and advanced care planning was positive and significant, it did not differ 
at lower levels of EA and the overall variation explained by the model was not significant.  
How then do the constructs examined in the study contribute to advanced care planning? 
In post-hoc hierarchical regression analyses that included demographic (age), distress, and 
interpersonal (social support, trust in physician) and intrapersonal factors (IU, EA), age was the 
strongest contributor to advanced care planning, followed by EA while IU approached 
significance. Older participants engaged in more advanced care planning. IU was positively 
though not significantly related to advanced care planning, whereas EA was negatively and 
significantly associated with advanced care planning.  
The proposed moderation model for advanced cancer planning was not supported by the 
data; nevertheless, hierarchical regression results suggest testing the model in samples that are 
less well-resourced, more diverse, and receiving care at less than top-tier medical centers would 




of illness and decline that is conducive to advanced care planning and palliative care.  However, 
cancer care at end-of-life is intensive and has been shown to differ by geographical region, local 
practice patterns, and insurance providers (Goodman et al., 2010; Morden et al., 2012; Teno et 
al., 2013). The finding that young and middle-aged patients engage in less advanced care 
planning is supported by previous research, with lack of awareness being among the most 
common reasons (Rao, Anderson, Lin & Laux, 2014). Younger age combined with greater EA 
suggest a combined vulnerability for non-elderly patients who have advanced cancer with respect 
to advanced care planning.  
The interpersonal factors, social support and trust in physician, did not evidence 
significant relationships with advanced care planning, which is inconsistent with other studies 
demonstrating the involvement of family members and the medical team (Boerner, Carr & 
Moorman, 2013; Chandar et al., 2019; Miyashita et al., 2019). Perceived support may make a 
potentially distressing activity less stressful and the medical team’s sensitivity to advanced care 
planning may facilitate productive discussions about documenting patient care preferences and 
executing directives. A possible reason for the nonsignificant influence of interpersonal factors 
in the current study may be the restricted range in the measures of social support and trust in 
physician: Most participants perceived high availability of support and reported high trust in 
physician.  
The current study did not assess negative interactions with patients’ social networks or 
medical professionals, which may be more strongly related to a lack of advanced care planning 
than perceptions of support or trust. Interactions with family and friends may not always be 
helpful in making end-of-life decisions. Advanced cancer is a stressor experienced by patients 




the patients (e.g., Hasson‐Ohayon, Goldzweig, Braun & Galinsky, 2010; Haun et al., 2014). 
Advanced care planning may stir up caregivers’ own anxieties about loss and death, and they 
may not be able to consistently provide the type of support needed by the patient or agree on 
end-of-life care preferences (Hwang, Keam, Kim, & Yun; 2016; Waller et al., 2018). Future 
research should examine transactional aspects of support during the advanced care planning 
process. 
Strengths and Limitations 
This study is the first of its kind to test a unique, theoretically-grounded model based on 
the social-cognitive processing framework to examine how intrapersonal and interpersonal 
factors influence emotional distress in a sample of individuals with advanced (Stage III and IV) 
cancers. The findings also explored how intrapersonal and interpersonal factors relate to 
advanced care planning, an understudied behavioral outcome in psycho-oncology and health 
psychology. The study utilized sophisticated statistical methods that assess direct, indirect, 
conditional indirect, and moderation effects to contribute to the state of the science on adaptation 
to illness in a disease context characterized by situational uncertainty. Importantly, the major 
findings of the study remained significant after controlling for demographic factors that were 
related to outcomes.  
There are, however, several limitations. The data are cross-sectional, limiting the ability 
to draw any temporal or causal conclusions. To offset this reality, the study hypotheses were 
theoretically-grounded and carefully considered to provide more meaningful information for 
future longitudinal studies. Furthermore, post-hoc analyses were conducted to allow for 




be possible in the advanced cancer context, longitudinal studies and replication can establish 
temporal precedent and strengthen the findings of the current dissertation.  
Common method bias may be a concern as the data in the current study came from self-
report instruments. Some strategies to reduce this bias may be to separate the measurement of the 
predictor and criterion variables via a time lag and collect data through different mediums (e.g., 
paper and pencil vs. computer/online). Collecting information from multiple sources may also 
hold utility. For example, in addition to the patient, a loved one could also be asked to complete 
a measure of perceived social support to ascertain how much perceived social support the loved 
one thinks the patient has.  
The sample was homogenous on many characteristics. Participants were predominantly 
white and of high socioeconomic status, receiving quality care at the world-renowned Memorial 
Sloan Kettering Cancer Center, preventing generalization of these findings to other advanced 
cancer populations.  The notable exceptions to this stark lack of diversity in background 
characteristics was a balanced breakdown between women (53%) and men (47%) and the range 
in types of cancers. Certain medical data were not available, such as time since diagnosis and 
whether the patients were still actively being treated. Furthermore, 25% of individuals who 
consented were unreachable and did not participate in the study. These individuals may not have 
initiated the study because of a lack of interest, time concerns and severity of physical symptoms 
or psychological distress.  
Larger, more diverse samples of individuals receiving care at different hospitals is an 
important direction for future research to establish external validity and generalizability of the 
models in this dissertation as well as to explore potential differences across types of cancers. 




with greater physical or psychological symptom severity. Collecting detailed information 
regarding medical characteristics and cancer care would allow for a more nuanced understanding 
of how the models tested in this study interact with time since diagnosis, type of treatment 
received and current treatment status.  
There was also a restricted range in many of the study variables. On average, participants 
reported high perceived availability of support and trust in physician, and these measures were 
negatively skewed. For example, on the trust in physician measure, the lowest score was 32 out 
of 55. Similarly, indices of emotional distress were positively skewed, with the majority of 
participants not reporting clinically significant levels of anxiety and depressive symptoms. 
Despite the restricted ranges some of the predicted findings emerged, lending credence to the 
proposed conceptual model given that significant effects are harder to detect under these 
conditions.  
Directions for Future Research 
Even though the current sample was well-resourced and receiving care at a top-quality 
cancer center in New York City and there were restricted ranges in some of the predictor and 
outcome variables, several hypotheses were supported. Nonetheless, previous research has 
documented relationships between race/ethnicity, financial stress, site of care, type of insurance 
and psychosocial adjustment in cancer populations (Apenteng, Hansen, Opoku & Mase, 2017; 
Brinkman-Stoppelenburg, Rietjens & van der Heide, 2014; Delgado-Guay et al., 2015). 
Consequently, the theoretically-grounded conceptual model presented in Figure 1 bears further 
testing in more socioeconomically and racially diverse groups of patients with advanced cancer, 




As patient burden was a concern, the number of measures that could be collected was 
constrained. The results of the study, however, suggest including measures of variables that 
might ‘explain’ the findings: negative social interactions (e.g., social constraints); cancer-specific 
distress and physical symptom burden (e.g., pain, sleep disturbance); and, anticipatory grief or 
death anxiety. Most measures of patient trust in physician were originally normed with primary 
care populations and/or tend to be generic rather than disease-specific (Anderson & Dedrick, 
1990; Hall et al., 2001). Recently, oncologist-specific measures of patient trust have been 
developed and may more accurately assess this component of the patient-physician dynamic in 
cancer populations (see Hillen, Postma, Verdam, & Smets, 2017). 
This study presented a first step toward understanding the intrapersonal and interpersonal 
factors that may influence end-of-life planning among patients with advanced cancer. More 
information is needed around patient-physician communication regarding prognosis and 
advanced care planning discussions. Future research might assess health professionals’ 
[dis]comfort around advanced care directives and/or talking to patients with advanced cancer 
about dying. Perhaps medical professionals with high IU also engage in more EA, which may 
affect if and how they engage in advanced care planning discussions with their patients. Patient 
reports of whether their medical professionals discussed advanced care planning with them, as 
well as how satisfied and informed patients felt after those discussions, would also provide 
meaningful information.  
Dyadic studies of patients and spouses/partners as well as patients and medical 
professionals are likely to yield more noteworthy, informative results about end-of-life planning.  
Coping with advanced cancer and the eventual possibility of dying occurs in a social context and 




perceived barriers in loved ones’ readiness to engage in advanced care planning? How might 
family members facilitate or impede this process?  
Clinical Implications  
How does an individual with advanced cancer come to terms with internal private events 
they may be experiencing, particularly if they are intolerant of uncertainty and, as such, prone to 
EA? Although this dissertation posited a social-cognitive processing model in which the 
interpersonal context would moderate the influence of intrapersonal factors, the overall findings 
provide support for cognitive processing theories of adjustment (Horowitz, 1986) for both the 
psychological (i.e., emotional distress) and behavioral (i.e., advanced care planning) outcomes.  
“Seek first to understand, then to be understood.” Dealing with advanced cancer 
involves a certain incomprehensible duality: vacillating between hope and fear, acceptance and 
denial, and living and dying (Jacobson et al., 2018). Existential issues are centerstage, which can 
be overwhelming and difficult to comprehend for patients and families. Targeting intrapersonal 
variables that are barriers to cognitive processing may be paramount as a first step of 
intervention before patients can begin to garner benefits from supportive, interpersonal 
relationships. In other words, patients may first want or need to begin understanding, accepting, 
or coming to terms with their own internal experiences before external factors, such as social 
support, can play buffering role.   
Intrapersonal targets for intervention. Two potential intrapersonal targets of 
intervention were examined in this study, IU and EA. Though IU has been conceptualized as a 
dispositional trait-like construct, implying that it remains relatively stable over time, several 
studies examining cognitive-behavioral interventions for patients with emotional disorders, have 




et al., 2015; Boswell, Thompson-Hollands, Farchionne, & Barlow, 2013) and depression 
(Talkovsky & Norton, 2018). The preponderance of CBT intervention research does not include 
an explicit therapy component that targets IU, although IU is considered to be a theoretically-
grounded intervention process variable (Rosser, 2019).  
Cognitive-behavioral interventions: IU as a mechanism of change. A hallmark of 
traditional cognitive behavioral treatment (CBT) differentiating it from third-wave cognitive-
behavioral interventions (e.g., acceptance and commitment therapy) is the focus on cognitive 
restructuring: identifying and challenging unhelpful, dysfunctional or irrational thinking. These 
cognitive strategies may potentially be less helpful in advanced cancer. For example, a patient 
with Stage II breast cancer who is more likely to construe uncertainty as negative or threatening 
and is sensitive to somatic symptoms may interpret a migraine as indicative of her cancer 
spreading and be anxious about dying. With this patient, we may challenge the catastrophization 
or the probability that the physical symptom she is experiencing is indicative of metastasis and 
death. Indeed, CBTs have demonstrated efficacy in early-stage and non-metastatic cancer 
patients (Andrykowski & Manne, 2006; Gudenkauf et al., 2015), although the majority of these 
studies have been conducted with individuals who have breast cancer (Zimmermann, Heinrichs, 
& Baucom, 2007). However, not all cancers are created equal and the strategies used in the 
scenario described above may not be effective for all patients with advanced cancer. 
Not all cancers are created equal. The average five-year survival rate for women with 
invasive breast cancer is 90% and over 60% are diagnosed when the cancer is localized to the 
breast, in which case the survival rate is 99% (American Society of Clinical Oncology [ASCO]; 
2019). In the current sample, no participants identified breast as their site of cancer, whereas 




presented above with a stage III lung cancer patient who has high IU, is experiencing an increase 
in physical symptoms, and is anticipating that a future negative might occur (e.g., disease 
progression). Given that the overall five-year survival rate for a lung cancer patient is 19% and 
the majority of patients are not diagnosed in the early stages (ASCO, 2019), challenging the 
probability of the worst-case outcome transpiring (e.g., dying) may not be counterproductive in 
the long-run for a prognostically-aware patient. A review of randomized controlled trials for 
CBT for patients with advanced cancers suggested that most studies utilized cognitive strategies 
and did not show consistent or significant treatment effects (Campbell & Campbell, 2012). Thus, 
therapists must be aware not only that the patient has cancer but also of the specific type of 
cancer, as each type brings with it different rates of treatment success and survival. Including this 
information in case conceptualizations will help identify appropriate cognitive and behavioral 
strategies to use with particular patients. 
Acceptance and commitment and meaning-centered psychotherapy: Targeting 
experiential avoidance. Traditional CBT generally adopts a problem-focused approach with the 
explicit goal to reduce emotional distress and change the content of various thoughts, whereas 
acceptance and commitment therapy (ACT) and meaning centered psychotherapy (MCP) 
endeavor to reduce symptom-related suffering and increase connection to valued activities or 
sources of meaning via acceptance (Breitbart et al., 2010; Hayes, Luoma, Bond, Masuda, & 
Lillis, 2006). Although other third-wave CBT or CBT-informed therapeutic modalities, such as 
emotion regulation therapy (Applebaum et al., 2018; Panjwani, O’Toole, Applebaum, Fresco, & 
Mennin, 2019) or emotional-focused therapy (Greenberg, 2004) may also be applicable, ACT 
and MCP have been previously applied to cancer patients and demonstrated clinical utility. As 




symptom-related suffering, and interference with valued activities are commonly experienced by 
patients with advanced cancer, ACT and MCP may be especially relevant in their therapeutic 
relevance for this population, both in terms of emotional distress and advanced care planning 
(Angiola & Bowen, 2013).  
Acceptance and commitment therapy. Compared to traditional CBT, ACT has been less 
commonly applied in cancer, much less advanced cancer. However, given that EA was found to 
be mediator of the relationship between IU and anxiety as well as IU and depressive symptoms, 
this therapeutic framework may have strong clinical implications for improving psychological 
and behavioral outcomes in advanced cancer though reductions in EA. Rather than directly 
changing unwanted thoughts or emotions, the core tenets of ACT encourage individuals to accept 
difficult internal experiences and develop new, compassionate relationships with them, which 
often reduces emotional distress as a byproduct and improves quality of life (González-
Fernández, Fernández-Rodríguez, Paz-Caballero & Pérez-Álvarez, 2018). 
Accepting rather than trying to control or stop these experiences helps individuals 
develop psychological flexibility, clarify their values and, subsequently, activate values-
consistent behavior (Angiola & Bowen, 2013; Hayes, 2005). In a study examining ACT among 
45 cancer patients, changes in acceptance predicted changes in anxiety, depressive symptoms 
and quality of life post-treatment that were also maintained at three-month follow-up (Feros, 
Lane, Ciarrochi & Blackledge, 2013). Only five of these patients had advanced disease, and the 
intervention was not tailored explicitly for individuals with advanced cancer. In another study, 
when behavioral activation was compared to ACT among cancer survivors, both interventions 
were related to decreases in emotional distress. ACT, however, demonstrated greater reductions 




with advanced cancer. A case study of a woman with advanced pancreatic cancer offers further 
support for how ACT offers utility at end-of-life (O’Hayer, O’Hayer & Sama 2018). Increasing 
acceptance, clarifying values and committing to taking values-informed actions motivated this 
woman to seek palliative care, take care of ‘unfinished business’, solidify relationships with 
family and friends, and reconnect to a sense of spiritual meaning, whereas prior to the 
intervention, she was “giving up” (O’Hayer et al., 2018). Taken together, the literature on ACT 
suggests unique promise for individuals with advanced cancer, not only in ameliorating 
emotional distress but also in enhancing the likelihood of engaging of end-of-life planning.  
Meaning-centered psychotherapy. In contrast to ACT, MCP was designed and 
developed for patients with advanced cancer with the explicit goal to enhance meaning, spiritual 
well-being, and quality of life (Breitbart et al., 2010; Breitbart et al., 2012; Greenstein & 
Breitbart, 2000; Rosenfeld et al., 2017). Although MCP does not explicitly test EA as 
mechanism of change in improving patient outcomes, the therapy aims to help individuals with 
advanced cancer reconnect with or enhance a sense of meaning as well as find peace and purpose 
in their lives as they confront—rather than experientially avoid—the possibility of death 
(Thomas, Meier, & Irwin, 2014). Moreover, direct discussions of death anxiety and related fears 
are facilitated along with patients working on personal legacy projects that center on what the 
patient finds meaningful (e.g., mending relationships, travelling, capturing their life story 
through blogs, books or videos, etc.).  
 A randomized controlled trial comparing group format MCP to supportive therapy found 
that MCP had stronger effects on spiritual well-being and sense of meaning and also reduced 
anxiety; neither therapy influenced depressive symptoms (Breitbart et al., 2010). In trial of 




or depressive symptoms. However, greater gains were observed in spiritual well-being, quality of 
life, number of endorsed physical symptoms, and distress related to physical symptoms among 
participants in the MCP condition compared to the massage condition (Breitbart et al., 2012). 
Taken together, the findings suggest promise for MCP as a relatively new therapy (compared to 
CBT and ACT) that is tailored to improve well-being among individuals living with advanced 
cancer and continuing to accrue empirical support.   
A need for more dedicated focus on advanced care planning. Cancer remains the second 
leading cause of mortality in the United States, with well over half a million deaths in 2017 
alone. Consequently, advanced care planning holds strong clinical relevance in oncology 
settings. Without advanced care directives, there is greater likelihood of a less dignified death, 
reduced quality of life, and a more complex bereavement process for the family as well as receipt 
of aggressive care that is not medically beneficial (Brinkman-Stoppelenburg et al., 2014; 
Detering et al., 2010). Patients may be reluctant to approach advanced care planning for a 
multitude of reasons. For example, they might equate advanced care planning with ‘giving up’ or 
find the topic too emotional distressing to have the necessary discussions with family and 
medical providers.  
Recall that current study findings suggest that greater EA predicts less advanced care 
planning, even after removing the influence of other factors. This highlights the importance of 
EA as an intervention target. Both ACT and MCP aim to reduce EA through actively cultivating 
acceptance of distressing emotions and thoughts rather than trying to dispute their validity or 
adaptability. The latter approach, more commonly utilized in CBT, may be invalidating for some 
individuals with advanced cancer as they are ultimately dealing with a terminal diagnosis and the 




2014). Decreases in EA through acceptance—rather than challenging—along with the focus on 
values/sources of meaning may be important gateways into introducing advanced care planning 
as a behavioral outcome in ACT and MCP interventions. Both therapies include components that 
could be adapted to promote decision-making around end-of-life directives. 
In ACT, psychological flexibility is cultivated through being present, opening up and 
doing what matters (Hayes et al., 2011). Clarifying patient values and activating behaviors 
consistent with those values may be a relevant segue into psychoeducation around advanced care 
planning, its benefits for patients and their loved ones (e.g., values-consistent medical care), as 
well as the potential harms of a lack of advanced care planning (e.g., medical care that is 
inconsistent with patients’ wishes). Quite similarly, when exploring different sources of meaning 
in MCP, after including a brief psychoeducation component on end-of-life planning, connections 
can be made to its benefits for the patient (e.g., a dignified death) and patients’ families (e.g., a 
less complex bereavement process for loved ones).  
The majority of interventions that target advanced care planning tend to only include 
decision aids, pamphlets or other forms of psychoeducation, and are seldom delivered by trained 
psychotherapists (Bakitas et al., 2009; Schubart, Levi, Bain, Farace, & Green, 2019; Stein et al., 
2013). Rarely do these interventions incorporate the theoretical and empirical knowledge of the 
clinical psychology field in increasing adaptive behavioral outcomes and reducing barriers to 
values-consistent goals. The importance of this fact is further underscored by the findings of this 
study, which suggest that reductions in EA improve engagement in end-of-life planning.  
Conclusions 
This dissertation is broadly centered on understanding how individuals manage the 




preparations for end-of-life. At the heart of the study was the dispositional construct of IU as it 
related to an illness characterized by situational uncertainty. Patients with advanced cancer, who 
have a reduced capacity to tolerate the unknown and the aversive reactions associated with the 
perceptions of situational uncertainty, are more likely to engage in EA of their internal 
environment (i.e., thoughts, emotions, bodily sensations, images and memories).  
Furthermore, the patient-physician relationship mattered, albeit in an unexpected way. 
Among those with high trust in physician, the indirect association between IU and anxiety 
through EA was stronger compared to those with lower or moderate trust in physician. The study 
also found that intrapersonal factors played a role in advanced care planning. Specifically, IU 
was positively related to advanced care planning and EA was negatively associated with 
advanced care planning. The findings of this theoretically-grounded dissertation suggest that 
intrapersonal factors play an important role in the adjustment of individuals living with advanced 
cancer, raise important questions for future research around the patient’s social context, and 
suggest clinical implications for emotional distress and advanced care planning.  
Although it is highly implausible that therapists can reduce the situational uncertainty 
experienced in the advanced cancer context, the psychological constructs of IU and, in particular, 
EA are identified as targets for intervention. Even though this dissertation cannot answer all 
questions pertaining to how individuals manage the emotional impact of advanced cancer and 
make end-of-life decisions, its findings provide support for the following idea: “The pain is 
there. When you close one door on it, it knocks to come in somewhere else” (Yalom, 2008), like 
an uninvited but persistent guest. Rather than attempting to consistently escape it, facing the 
night side of life may ultimately foster better emotional and behavioral health outcomes for 





Table 1   
Demographic and Medical Characteristics 
Characteristic n   % 
Age, M = 63 (SD = 11)   
Female 57 53 
Race   
    White 95 88 
    Black   4    4 
    Asian/Pacific Islander   3   3 
    Othera   4    4 
    Missing   2   2 
Hispanic   6    6 
Relationship status   
    Married/partnered 74 69 
    Single 10   9 
    Divorced/separated 14 13 
    Widowed   6   6 
    Missing   4   4 
Household income   
    < $10,000 - $40,000 11 10 
    $40,000 - $75,000 16 15 
    $75,000 - $150,000 34 32 
    > $150,000 37 34 
    Missing 10   9 
Education    
     Some high school    3   3 
     High school graduate 12 11 
     Some college 16 15 
     College graduate 34 32 
     Graduate or professional degree 39 36 
     Missing   4   4 
Employment   
     Employed full-time 27 25 
     Employed part-time   7   7 
     Retired 45 42 
     Disabled or on leave 15 14 
     Homemaker   3   3 
     Other   6   6 




Table 1 (continued)      
 
Characteristic n   % 
Had psychiatric illness 18 17 
     Anxiety    5   5 
     Depression   4   4 
     Comorbid depression and anxiety   3   3 
     Otherc   6   5 
Cancer site(s)   
     Digestive system 30 28 
     Genitourinary   5   5 
     Gynecologic 20 19 
     Head and neck   5   5 
     Lymphoid neoplasms   1   1 
     Thorax 16 15 
     Multiple sites or metastasis 29 27 
     Missing   2   2 
Patient report of cancer staged   
     Stage III 13 12 
     Stage IV 66 61 
     Patient does not know 16 18 
     Othere   7   4 
     Missing   6   6 
Note. N = 108. Percentages were rounded and may not sum to 100.  
aOther includes Middle-Eastern (n=1), mixed race (n=1), and unspecified 
(n=2). bOther includes semi-retired (n=1). cOther includes cancer-related 
stress (n=1), “I have a wonderful therapist!” (n=1) and “I am here today to 
receive psychiatric care” (n=1), depression & attentional deficit 
hyperactivity disorder (n=1), borderline personality disorder (n=1)  and 
unspecified (n=1). dAll participants had cancers that were classified as 
advanced per electronic medical record review and were, therefore, eligible 
for the study. eOther included patients who classified their staging 




























































































































































































































































































































































































































































































































































































































































































































































































































































HADS Frequencies for Current Sample Based on Cutoffs for Oncological Populations 
Score n (%) 
Anxiety symptoms (HADS-A) 
    Clinical
a
  > 3 77 (71) 
    Balanced
b
 > 7 35 (32) 
Depressive symptoms (HADS-A) 
    Clinical  > 2 73 (68) 
    Balanced > 5 33 (31) 
Emotional Distress (HADS-Total) 
    Clinical > 6 67 (62) 
    Balanced > 13 25 (23) 
Note. HADS=Hospital Anxiety and Depression Scale; HADS-A=Hospital Anxiety and Depression 
Questionnaire-Anxiety Subscale; HADS-D=Hospital Anxiety and Depression Questionnaire-Depression 
Subscale. 
a
Clinical=recommended score for clinical purposes, that is, sensitivity min 0.95. 
b
Balanced= 
best trade between sensitivity and specificity. 




Frequencies of Advanced Care Planning Checklist Items 
Advanced Care Planning Checklist Items n % 
I have discussed the following with my medical provider: 
   My prognosis 85 79 
   My goals of care, for now and in the future 72 67 
   My concerns about end-of-life care   9   8 
   My hopes and wishes about the future 32 30 
   My DNR status 15 14 
I have discussed the following with a loved one: 
   DNR orders 60 56 
   Designation of a healthcare proxy 79 73 
   Designation of power of attorney 62 57 
   Living will/advanced directive 71 66 
I have executed the following: 
   DNR 44 41 
   Designation of a healthcare proxy 81 75 
   Designation of power of attorney 54 50 
















































   

























































































































































































































































































































































































































































































































































































































































































































































Correlations between Continuous Demographic and Main Study Variables 
Variable Age Income Education 
1. Intolerance of uncertainty (IUS-12)  .12           -.16          .03 
2. Experiential avoidance (BEAQ)  .15  -.27**         -.23* 
3. Social support (FSSQ)        -.02   .32**          .15 
4. Trust in physician (TiPS)        -.10           -.07         -.01 
5. Emotional distress (HADS) -.08  -.38**         -.11 
6. Anxiety symptoms (HADS-A)  -.18†           -.31**         -.08 
7. Depressive symptoms (HADS-D)        -.07  -.38**         -.13 
8. Advanced Care Planning (ACPC)      .34**            .09  .22* 
Note. IUS-12=Intolerance of Uncertainty 12-Item Scale; BEAQ=Brief Experiential Avoidance 
Questionnaire; FSSQ=Functional Social  Support Questionnaire; TiPS=Trust in Physician Scale; HADS= 
Hospital Anxiety and Depression Scale; HADS-A=Hospital Anxiety and Depression Questionnaire-
Anxiety Subscale; HADS-D=Hospital Anxiety and Depression Questionnaire-Depression Subscale; 
ACPC=Advanced Care Planning Checklist 




Intercorrelations of Main Study Variables 
Variable 1 2 3 4 5 6 7 
1. Intolerance of uncertainty (IUS-12) - 
2. Experiential avoidance (BEAQ)  .43** - 
3. Social support (FSSQ) -.26** -.26** - 
4. Trust in physician (TiPS) -.16† -.08 .27** - 
5. Emotional distress (HADS)  .42**  .42** -.32**   -.06 - 
6. Anxiety symptoms (HADS-A)  .40**  .37** -.30**   -.01 .92** - 
7. Depressive symptoms (HADS-D)  .36**  .38** -.26**   -.12 .88**  .63** - 
8. Advanced Care Planning (ACPC)  .18† -.05  -.03   -.01 .03  .03 .03 
Note. IUS-12=Intolerance of Uncertainty 12-Item Scale; BEAQ=Brief Experiential Avoidance 
Questionnaire; FSSQ=Functional Social  Support Questionnaire; TPS=Trust in Physician Scale; HADS= 
Hospital Anxiety and Depression Scale; HADS-A=Hospital Anxiety and Depression Questionnaire-
Anxiety Subscale; HADS-D=Hospital Anxiety and Depression Questionnaire-Depression Subscale; 
ACPC=Advanced Care Planning Checklist 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2. Conceptual model of experiential avoidance moderating the relationship between 







Figure 3a. This figure depicts the statistical diagrams of simple mediation for the indirect effect 
of intolerance of uncertainty on anxiety symptoms through experiential avoidance. X=predictor, 
M=mediator, Y=outcome. 
Figure 3b. This figure depicts the statistical diagrams of simple mediation for the indirect effect 
of intolerance of uncertainty on depressive symptoms through experiential avoidance.  




Figure 4a. This figure depicts the statistical diagram of moderated mediation for the conditional 
indirect effects of intolerance of uncertainty (through experiential avoidance) on anxiety 
symptoms as a function of social support. X=predictor, M=mediator, W=moderator, 
M*W=product term for mediator and moderator, Y=outcome. 
Figure 4b. This figure depicts the statistical diagram of moderated mediation for the conditional 
indirect effects of intolerance of uncertainty (through experiential avoidance) on anxiety 
symptoms as a function of trust in physician. X=predictor, M=mediator, W=moderator, 




Figure 5a. This figure depicts the statistical diagrams of moderated mediation for the conditional 
indirect effects of intolerance of uncertainty (through experiential avoidance) on depressive 
symptoms as a function of social support. X=predictor, M=mediator, W=moderator, 
M*W=product term for mediator and moderator, Y=outcome. 
Figure 5b. This figure depicts the statistical diagrams of moderated mediation for the conditional 
indirect effects of intolerance of uncertainty (through experiential avoidance) on depressive 
symptoms as a function of trust in physician. X=predictor, M=mediator, W=moderator, 
















Figure 6. This figure depicts the statistical diagram of experiential avoidance moderating the 
influence of intolerance of uncertainty on advanced care planning. X=predictor, W=moderator, 







Figure 7. This figure depicts the moderating effect of trust in physician on the relationship 
between experiential avoidance and anxiety symptoms at low (-1 SD below the mean), average 





Figure 8. This figure depicts the moderating effect of trust in physician on the relationship 
between experiential avoidance and anxiety symptoms at low (-1 SD below the mean), average 
(mean), and high (+1 SD above the mean) levels of trust in physician, controlling for gender and 




Figure 9. Alternative conceptual model for both intrapersonal and interpersonal factors 
influencing emotional distress among patients with advanced cancer. The indirect effect of 
intolerance of uncertainty on emotional distress is proposed to be a function of social support and 
trust in physician; the moderating influence of these interpersonal factors is depicted as “acting” 
on the association between intolerance of uncertainty and experiential avoidance (first stage 










Figure 10. Alternative conceptual model of second stage multiple moderated mediation, wherein 
the interpersonal factors are mediators (social support, mediator 1; trust in physician, mediator 2) 

















Figure 11. Alternative conceptual model for second stage moderated parallel mediation model 
wherein the relationship between intolerance of uncertainty and distress is mediated through 
patients’ level of social support (mediator 1) and trust in their physician (mediator 2), and these 





























Figure 12. This figure depicts the moderating effect of experiential avoidance (EA) on the 
relationship between patient trust in physician and anxiety symptoms at low  (-1 SD below the 
mean), average (mean), and high (+1 SD above the mean) levels of EA, controlling for gender 





















Appendix A:  
















































































Appendix B:  









































Intolerance of Uncertainty Scale-Short Form (IUS12-SF) 
 











ic of me 
Entirely 
characteris
tic of me 
1. Unforeseen events upset me greatly. 
1 2 3 4 5 
2. It frustrates me not having all the 
information I need. 
1 2 3 4 5 
3. Uncertainty keeps me from living a 
full life. 
1 2 3 4 5 
4. One should always look ahead so as 
to avoid surprises. 
1 2 3 4 5 
5. A small unforeseen event can spoil 
everything, even with the best of 
planning. 
1 2 3 4 5 
6. When it’s time to act, uncertainty 
paralyses me. 
1 2 3 4 5 
7. When I am uncertain I can’t function 
very well. 
1 2 3 4 5 
8. I always want to know what the 
future has in store for me. 
1 2 3 4 5 
9. I can’t stand being taken by surprise. 
1 2 3 4 5 
10. The smallest doubt can stop me 
from acting. 
1 2 3 4 5 
11. I should be able to organize 
everything in advance. 
1 2 3 4 5 
12. I must get away from all uncertain 
situations. 




















































Trust in Physician Scale 
 
Please answer the following questions in relation to the physician who is most responsible for 












1. I doubt that my doctor really cares 












2. My doctor is usually considerate of my 
needs and puts them first. 
 
1 2 3 4 5 
3. I trust my doctor so much that I always 
try to follow his/her advice. 
 
1 2 3 4 5 
4. If my doctor tells me something is so, 
then it must be true. 
 
1 2 3 4 5 
5. I sometimes distrust my doctor's 
opinion and would like a second one. 
 
1 2 3 4 5 
6. I trust my doctor's judgment about my 
medical care. 
 
1 2 3 4 5 
7. I feel my doctor does not do everything 
he/she should for my medical care. 
 
1 2 3 4 5 
8. I trust my doctor to put my medical 
needs above all other considerations when 
treating my medical problems. 
 
1 2 3 4 5 
9. My doctor is a real expert in taking care 
of medical problems like mine. 
 
1 2 3 4 5 
10. I trust my doctor to tell me if a mistake 
was made about my treatment. 
 
1 2 3 4 5 
11. I sometimes worry that my doctor may 
not keep the information we discuss 
totally private. 















Hospital Anxiety and Depression Scale (HADS) 
 
Instructions:  Read each item and please circle the answer which comes closest to how you 
have been feeling, on the average, in the past week.  Don’t take too long over your answers; your 
immediate reaction to each item will probably be more accurate than a long thought out response 
 
1. I feel tense or ‘wound up’: 
 a. Most of the time 
 b. A lot of the time 
 c. From time to time, occasionally 
 d. Not at all 
 
2. I still enjoy the things I used to enjoy: 
 a. Definitely as much 
 b. Not quite so much 
 c. Only a little 
 d. Hardly at all 
 
3. I get a sort of frightened feeling as if something awful is about to happen: 
 a. Very definitely and quite badly 
 b. Yes, but not too badly 
 c. A little, but it doesn’t worry me 
 d. Not at all 
 
4. I can laugh and see the funny side of things: 
 a. As much as I always could 
 b. Not quite so much now 
 c. Definitely not so much now 
 d. Not at all 
 
5.      Worrying thoughts go through my mind: 
 a. A great deal of the time 
 b. A lot of the time 
 c. From time to time but not too often 
 d. Only occasionally 
 
6. I feel cheerful: 
 a. Not at all 
 b. Not often 
 c. Sometimes 
 d. Most of the time 
  
7. I can sit at ease and feel relaxed: 
 a. Definitely 
 b. Usually 
 c. Not often 










8.  I feel as if I am slowed down: 
 a. Nearly all the time 
 b. Very often 
c. Sometimes 
d. Not at all 
 
9. I get a sort of frightened feeling like 'butterflies' in the stomach:  
  a. Not at all 
b. Occasionally 
c. Quite often 
d. Very often 
 
10. I have lost interest in my appearance: 
 a. Definitely 
 b. I don't take as much care as I should 
 c. I may not take quite as much care 
 d. I take just as much care as ever 
 
11. I feel restless as if I have to be on the move: 
 a. Very much indeed 
 b. Quite a lot 
 c. Not very much  
 d. Not at all 
 
12. I look forward with enjoyment to things: 
 a. As much as ever I did 
 b. Rather less than I used to 
 c. Definitely less than I used to 
 d. Hardly at all 
 
13. I get sudden feelings of panic: 
 a. Very often indeed 
 b. Quite often 
 c. Not very often 
 d. Not at all 
 
14.  I can enjoy a good book or radio or TV program:  
  a. Often  
  b. Sometimes 
  c. Not often  















Advanced Care Planning Checklist 
 
I have discussed the following with my healthcare provider (check all that apply): 
____ My prognosis 
____ My goals of care, for now and in the future 
____ My concerns about end-of-life care 
____ My hopes and wishes for the future 
____ My DNR status 





I  have discussed the following with a loved one (check all that apply): 
____ DNR (Do-Not-Resuscitate) Orders 
____ Designation of a health care proxy 
____ Designation of a power of attorney 
____ Living will/advanced directive 





I have executed the following (check all that apply): 
____ DNR (Do-Not-Resuscitate) Order 
____ Designation of a health care proxy 
____ Designation of a power of attorney 



























Appendix D:  
Social Support as Moderator of Indirect Influence of IU on Anxiety Symptoms with Sex and 
Income as Covariates (Hypothesis 2a) 
 The model tested whether EA, as the mechanism through which IU influences anxiety 
symptoms, was contingent on the extent to which participants felt supported by their social 
network when covariates sex and income were added to the equation. The analysis was 
conducted with the 98 participants who provided data on income. The index of moderated 
mediation remained nonsignificant (αb3 = -.0005, SE = .002, 95% CI: -.003, .004). The 
interaction term of EA x social support also remained nonsignificant (b3 = .0007, SE = .002; 95% 
CI: -.004, .005).  Holding EA, social support, the interaction term and covariates constant, the 
direct relationship between IU and anxiety symptoms remained significant (c’ = .12, SE = .05; 
95% CI: .02, .22). The total variance explained by the model was R2 = .35, F(6, 91) = 7.37, p < 
.0001. In sum, although there was a direct relationship between IU and anxiety symptoms, no 
conditional indirect effects of IU by social support were observed when covariates sex and 

















Social Support and Trust in Physician as Moderators of the Indirect Influence of IU on 
Depressive Symptoms with Income as Covariate (Hypothesis 3a and 3b) 
Hypothesis 3a Recomputed with Income as Covariate 
This model tested whether EA as the mechanism through which IU is related to 
depressive symptoms, was contingent on the extent to which participants felt supported by their 
social network, if income was included as a covariate (n = 98). The index of moderated 
mediation remained nonsignificant (αb3 = .001, SE = .002, 95% CI: -.003, .004). The interaction 
term of EA x social support also remained nonsignificant (b3 = .001, SE = .002; 95% CI: -.003, 
.005). The indirect relationship between IU and depressive symptoms through EA was not a 
function of social support even when income was included as a covariate. Holding EA, social 
support, income, and the interaction term constant, the direct association of IU on depressive 
symptoms was not significant (c’ = .08, SE = .04; 95% CI: -.007, .16). The total variance 
explained by the model was R2 = .28, F(5, 92) = 7.17, p < .0001. The model was not interpreted 
further.    
Hypothesis 3b Recomputed with Income as Covariate 
  This model tested whether EA as the mechanism through which IU influences depressive 
symptoms, was contingent on participants trust in physician, if income was covaried (n = 98). 
The index of moderated mediation remained nonsignificant (αb3 = .003, SE = .004, 95% CI: -
.004, .01). The interaction term of EA x trust in physician also remained nonsignificant (b3 = 
.004, SE = .004; 95% CI: -.005, .01). The indirect relationship between IU and depressive 
symptoms through EA was not a function of  trust in physician even when income was included 








direct association between IU and depressive symptoms was not significant (c’ = .08, SE = .04; 
95% CI: -.005, .16). The total variance explained by the model was R2 = .29, F(5, 92) = 7.50, p < 




























Appendix F:  
The Moderating Role of EA on the Relationship Between IU and Advanced Care Planning When 
Age Was Included as a Covariate (Hypothesis 4) 
Simple moderation analysis was used to test whether EA moderated the relationship 
between IU and advanced care planning if age was included as a covariate. No interaction 
between IU and EA was found (b3 = -.001, SE: .004; 95% CI: -.01, .008). The  relationship 
between EA and advanced care planning remained nonsignificant (b2 = -.07, SE = .03; 95% CI: -
.13, .001). However, there was a significant direct relationship: Controlling for EA, age and the 
interaction term, participants with greater IU engaged in more advanced care planning (c’ = .13, 
SE = .06; 95% CI: .008, .24). The total variance in advanced care planning explained by the 





















Statistical Diagram and Results for Parallel Mediation Model Tested in Post-Hoc Analysis 4b 
 The following figure presents the regression coefficients and standard errors for a parallel 
mediation analysis for post-hoc analysis 4b, which tested whether the relationship between 
intolerance of uncertainty (IU) and depressive symptoms is mediated by social support (mediator 
1) and trust in physician (mediator 2). Gender and income were included as covariates. IU did 
not have an indirect influence through social support (αb1cs = .01, SE = .01; 95% CI: -.01, .04) or 
trust in physician (αb2cs = .01, SE = .01; 95% CI: -.01, .04); however, the direct association 
between IU and depressive symptoms remained significant. The variance accounted for by the 
model is R2 = .25, F(5, 92) = 6.27, p = < .0001.  
 
 
Figure G1. This figure depicts the regression results for a parallel mediation model, examining 
whether the relationship between intolerance of uncertainty and depressive symptoms was 
mediated by social support (mediator 1) and trust in physician (mediator 2). Unstandardized 
coefficients are reported.  
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